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ABSTRACT

PROPERTIES OF TERATOCARCINOMA SOMATIC CELL HYBRIDS

Richard A. Miller
Yale University 1977

This dissertation describes the production and characterization of two
series of somatic cell hybrids.

PCT hybrids result from the fusion of

mouse thymocytes with PCC4azal embryonal carcinoma cells (pluripotent
cells derived from a mouse teratocarcinoma)<

PCF hybrids arise from the

fusion of PCC4azal with FBU, a line of Friend erythroleukemia cells.
These hybrid cells resemble their embryonal carcinoma parents in many
ways.

They look like PCC4azal by phase contrast and electron microscopy.

Like embryonal carcinoma cells, they have high levels of alkaline phosphatase.
They are resistant to infection by a parvovirus, MVM, which can infect many
mouse cell lines, but not embryonal carcinoma cells.

The hybrids also

produce tumors which contain a variety of cell types, including derivatives
of all three of the classical germ layers.

The most highly-differentiated

tumors produce mouse a-fetoprotein.
Traits characteristic of the non-pluripotent parental cell line, such
as Thy-1 antigen in thymocytes, and acetylcholinesterase in Friend cells,
are not expressed in the hybrid cells.

PCC4azal and FBU also differ in their

pattern of lactate dehydrogenase isozymes, and the PCF cells resemble
PCC4azal in this respect, too.

PCF populations, unlike those of FBU,

do not contain hemoglobinated cells.
At least some of the cells in PCT populations do, however, exhibit H-2
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antigens, which are expressed only at very low levels, if at all, in the
PCC4azal parental cells.
These experiments show that although embryonal carcinoma cells can,
under appropriate developmental conditions, give rise to thymocytes and
erythroblasts, the genome of the pluripotent cell does not respond to
the signals that these two differentiated cell types use to maintain
their stable epigenetic state.

On the contrary, pluripotent cells may

contain a molecular mechanism able to "reset" the genetic apparatus of a
differentiated cell.
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A Note on Terminology

I wish to state here how I intend to use certain terms often employed
by other writers in diverse ways.
Teratoma, teratocarcinoma, embryonal carcinoma, embryoma:

I intend

to use these terms in the ways suggested by Damjanov and Solter (1974), and
by Stevens and Pierce (1975).

Teratocarcinomas are transplantable tumors

which contain cells of many different tissue types.

Some of the cells in

teratocarcinoma.?: are embryonal carcinoma cells, which are thought to render
the tumor transplantable, and are thought to be the cell type from which all
the other types are derived.

The word "teratoma" is commonly used in two

senses: first, to denote a teratocarcinoma-like tumor which is not, however,
transplantable (because it contains no embryonal carcinoma cells); and second,
as a lumping term which includes both the transplantable and non-transplantable varieties.

I shall use the word in both senses, and use the phrase

"benign teratoma" when clarity requires it.

Embryomas are growths which,

like teratomas, contain a variety of cell types, but do not have the potential
to grow continuously and never have contained embryonal carcinoma cells.
Embryomas can be produced experimentally by the ectopic implantation of mouse
embryos after the developmental stage at which transplantable teratocarcinomas
can last be produced.
Embryo versus conceptus:

strictly speaking, the conceptus includes both

the embryo proper and the extra-embryonic membranes.

I shall, however, use

the word "embryo" as synonymous with "conceptus," and the phrase "embryo
proper" when distinction from extra-embryonic membranes is needed.
Malignant, transplantable, transformed, tumorigenic:

to call tumors

transplantable, and cells tumorigenic, gives no one any trouble, since the
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terms are operational.

I shall avoid the term "transformed" unless it is

clear what is being transformed by what.

It is, for example, by no means

clear that embryonal carcinoma cells, although tumorigenic, have undergone
any sort of transformation.

Some people use "malignant" to mean "meta

stasizing," and others as a synonym for "transplantable;"

I shall avoid

its use.
Pluripotent, determined, differentiated:

the confusion these terms

evoke reflects, in part, our ignorance of the decision-making process within
the embryo.

I will restrict the use of "pluripotent" to those cells which can

give rise to several kinds of fundamentally different cells.

Friend cells are

not, in this sense, pluripotent, even though they can give rise to normoblast
like cells different in many ways from ordinary Friend erythroblastoid cells.
I consider a cell "determined" or "committed" when it has entered into that
ill-defined state from which it can, under ill-defined "normal" conditions,
produce only the limited variety of cell types towards which it has just become
determined.

We know, since leukocyte albumin genes can be activated under some

conditions (e.g. Darlington et al., 1974), that abnormal conditions can undo
the effects of determination.

I will not fall for the etymological cavil

that says "all cells are differentiated" just because they all look different.
A differentiated cell, as I shall use the term, is one that has attained a
state in which it remains stable within limits defined by the cell cycle (if
still dividing) and modulating influences (e.g. hormones).

A stem cell, all

of whose progeny are either stem cells or (e.g.) epidermal cells, is determined
but not yet differentiated.

In the past, many somatic cell geneticists have

called some particular cell line (usually fibroblastoid) "undifferentiated"
because these cells were unlike the differentiated cell line with which they
were being compared or fused.

I do not use the term in this way; when one

fuses a fibroblast with an embryonal carcinoma cell, it makes little sense to
call the former cell undifferentiated.
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LIS T OF ABBREVIATIONS

AChE:

acetylcholinesterase

APase:

alkaline phosphatase

C?: complement
DMSO: dimethyl sulfoxide
DVME:

Dulbecco-Vogt modified Eagle's medium

DVME-FC:

DVME with 10% fetal calf serum

DVME-HAT:
DVME-o:
ECC:
EDTA:

DVME with HAT additives
DVME without any additives (except antibiotics)

embryonal carcinoma cell
ethylene diamine tetra-acetate

FBU:

a line of BrdU-resistant Friend erythroleukemic cells

FCS:

fetal calf serum

GPI:

glucose phosphate isomerase

HAT:

a mixture of hypo-:anthine, aminopterin and thymidine; concentrations
are given in the text

IDH:

isocitrate dehydrogenase

LDH:

lactate dehydrogenase

MOI:

multiplicity of infection

MPC:

mesectodermal precursor cell

MVM:

minute virus of mice

PCC4azal:

an azaguanine-resistant embryonal carcinoma cell line

PCF:

a line of PCC4azal x FBU hybrids

PCT:

a line of PCC4azal x thymocyte hybrids

PFU: plaque-forming units
PGC:

primordial germ cells

PGM:

phosphoglucomutase
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"Ifm worried about Paul,"

Martha said.

"Hasn’t he done this kind of thing before?"
laugh.

Helen essayed a reassuring

"I’d gathered this was more or less normal with him and Nicole."

"Yes, but...it was different when she was with him.
him go on like this.

It’s been over two weeks!

She never let

I don't know what to do—

he won't let me help him."
Gordon, who was doing sit-ups, grunted for attention.
best thing that could have happened," he interjected.
involved with his work.

"Probably the

"I mean, getting

Martha ought to know that."

7:00 a.m., October 24.

Tape recording (Paul Holliston):

"Administering 500 cc of Methotrexate...a risk, because of its high
addictive quality.

If Methotrexate doesn't arrest the rapid growth, I have

no choice but to transfer the subject to the University Research Clinic.
I can no longer cope..."

— From

F.Tnbryo,

by Louis Charbonneau.

Based on the screenplay by

Anita Doohan and Jack W. Thomas.

r* - -

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

CHAPTER ONE:

PART 1A:

INTRODUCTION

Somatic cell hybrids as tools with which to study patterns of

gene expression

The central theme of this dissertation is that there are rules
which specify the patterns of gene expression which a cell can adopt
and which govern the changes from one pattern to another, and that one
can obtain insights into these rules by characterizing somatic cell
hybrids whose parents differ epigenetically.
This theme is by no means new.

Indeed, the earliest experiments

Harris performed after he and Watkins (Harris and Watkins, 1965)
introduced Sendai-virus-mediated cell fusion as a means of promoting
somatic cell hybrid formation were based on such expectations.

In

these studies (reviewed in Harris, 1970), Harris and his collaborators
showed that when heterokaryons were formed between two cell types, of
which only one made RNA (or both RNA and DNA) , nucleic acid synthesis
in the nucleus of the less active parent was induced to match the
pattern of the other parent.

Since these reports, a large literature

has accumulated based on the characterization of hybrids and hetero
karyons whose parents differed epigenetically.

I intend to draw upon

this literature only to illustrate the principles discussed below;
more comprehensive reviews are available (Davis and Adelberg, 1973;
Davidson, 1974).
The work of Davidson and his collaborators on melanoma x fibro
blast hybrids not only presented the first detailed study of

1

fry
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"intertypic" hybrid cells (i.e., hybrids whose parents were of
different epigenetic types), but also suggested two generalizations
which later work has, for the most part, supported.

An early report

(Davidson et al., 1966) showed that Syrian hamster melanoma x mouse
L cell fibroblast hybrids were unpigmented; later work (Davidson,
1972) demonstrated that hybrids formed between the same fibroblast
line and a melanoma line related to the first one but containing
twice the chromosome number were often pigmented.
One generalization suggested by these findings is that L cell
traits predominate in hybrids formed by fusing 1 cells with other
kinds of cells.

Many intertypic fusions have involved L cells or

other aneuploid fibroblastoid lines with long histories of growth
in vitro.

During the course of such a long and sometimes quixotic

selection for cells which grew well under artificial conditions (see
Ham (1974) for a resume of the trials of the L cell line), inadvertant
selection may also have occurred for cells unusually able to dominate
intertypic fusions with parents less well adapted to culture.

In

hybrids between these aneuploid fibroblasts and other cell types,
extinction of the tissue-specific phenotypes of the nonfibroblast
parent often takes place.
Table 1-1.

A selection of such reports is shown in

This table also shows, however, that while the "rule" of

fibroblast extinction is consistent with the results of many cell
fusion experiments, much of the data is equally consistent with the
hypothesis that relative chromosome input ("gene dosage") determines
hybrid properties.

A "pure" test of this "fibroblast extinction" rule

would require that one fuse a given nonfibroblast line with a number
of other kinds of cells, including aneuploid fibroblasts, while

ia-,~__
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TABLE 1-1
REPRESENTATIVE FIBROBLAST HYBRIDS

Other Cell

Property

Melanoma

melanin

Chromosomes
Fibro.
Other
52
52

51
91

Results

Reference

extinction
retention
(some olonei

Davidson et^ al., 1966
Davidson 1972

S-100 protein

53, 75
53

42
2x 42

extinction
^extinction

Benda and Davidson, 1971

GPDH (baseline)

53
53

42
2x 42

extinction
retention

Davidson and Benda, 1970

GPDH (induced)

53
53

42
2x 42

extinction
^extinction

Pituitary

Growth hormone

2x 50

73

extinction

Renal

Esterase-2

45

73

^extinction

Neural

various

52

90, 142

47

92

Glial

retention
(some props

Sonnenschein et al., 1971
Klebe «rt al^., 1970
Minna et^ al., 1972
McMorris and Ruddle, 1974

Thymic

Thy-1 antigen

50-55

ca. 40

extinction

see Table 1-2

Friend

globin or its
mRNA

45-70
22 (a)

37-40
37-40

extinction
retention

see Table 1-3

NOTES:

* indicates an exception to the "gene dosage hypothesis"
(a) clones which segregate nearly all their human fibroblast chromosomes also make globin mRNA.
Data on liver cells has been omitted; see Darlington and Ruddle (1975) for a review.
The work on Friend and thymic cells has been synopsized; see text for greater detail.

4

controlling for the effects of gene dosage.

No such set of experiments

has been reported.
"Pure" tests of the effects of gene dosage on hybrid character
have been carried out.

In addition to the work of Davidson (1972),

and the work of Fcugere et al. (1972) on similar melanoma hybrids,
the studies of Davidson and Benda (1970) on glycerol-3-phosphate
dehydrogenase in gliai-fibroblast hybrids support the idea that histo
typic functions extinguished in a set of 1:1 hybrids can nonetheless
appear in 2:1 nonfibroblast:fibroblast combinations.

The data of

Peterson and Weiss (1972) on albumin expression in hepatoma hybrids
suggest similar conclusions.
Studies of mtertypic hybrids have demonstrated four other
phenomena, each of which imposes its own constraints on molecular
models of gene regulation.

The first I want to mention among these

is the finding of Peterson and Weiss (1972) and of Darlington et al.
(1974) that a gene which is not expressed in a particular parental cell
type can be activated when this parent is fused to a cell in which the
gene is expressed.

In the first of these studies, the albumin gene

of a mouse fibroblast was shown to have been "turned on" by fusion
with (probably two) rat hepatoma cells.

In the other, human albumin

production was demonstrated in a mouse hepatoma x human leukocyte
hybrid, in which the hepatoma genome was again at the 2S level.

These

studies do not explain how hepatoma cells maintain their albuminproducer status nor how leukocytes and fibroblast maintain their
nonproducer state, but do prove that subversion of the latter mechanism
by the former is possible.
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A second phenomenon, that of production, by a hybrid, of molecules
not produced by either parental cell type, is illustrated by the
demonstration (McMbrris and Ruddle, 1974) of choline acetyltransferase
in a mouse neuroblastoma x human fibroblast hybrid, and by the demon
stration of morphine receptors in neuroblastoma x glioma hybrid cells
(Klee and Nirenberg, 1974).

It is possible in each case that the

property in question could have been present in a small proportion of
the neuroblastoma population, and that one of these few cells may have
been "captured" by hybrid formation; most hybrid clones in the series
studied do not show the "new" activity.
The third phenomenon I wish to mention is that of dissociation,
in a hybrid, of differentiated properties which occur together in all
the cells of one of the parental populations. Minna et al. (1972),
for example, have examined a series of neuroblastoma x fibroblast
hybrid lines to see which of the several distinct neuroblastoma marker
phenotypes were expressed.

They found some hybrid clones in which many

of the neural properties were present, and others in which only a
subset could be demonstrated.

Some of the traits (e.g. action potential

production) seemed to be present only in hybrids which already possessed
others (e.g. acetylcholinesterase).

Tests of a larger series of hybrids

might have provided these authors with exceptions to their proposed
hierarchy of markers.

The hierarchy suggested by their results may,

however, be relevant to the sequence of transitions among epigenetic
states which occurs in developing neural tissues.

An analogous experi

ment by Szpirer and Szpirer (1975) has shown that mouse hepatoma x
mouse or rat fibroblast hybrid cells can retain the ability to secrete
transferrin and C3 (third component of complement, secretion of which

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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is characteristic of the hepatoma cells) but lose the capacity to
produce albumin and a-fetoprotein.

These "dissociation" experiments

begin to suggest the extent to which particular differentiated pheno
types are dependent on others with which they are usually associated.
The fourth lesson I wish to abstract from the library of intertypic
fusions is that chromosome loss can be accompanied by re-expression of
a differentiated phenotype which had been extinguished in the original
hybrid cells.

The two studies most often quoted in this context are

the work of Klebe et al. (1970b) on reappearance of a kidney-specific
esterase in segregating mouse renal adenocarcinoma x human fibroblast
hybrids, and that of Weiss and Chaplain (1971) on reappearance of
tyrosine aminotransferase inducibility in rat hepatoma x rat liver
epithelial cell hybrids.

A further example is provided by the finding

of Kao and Puck (1972) that expression of a group of Chinese hamster
esterases was dependent on retention of a single human chromosome in
a set of hamster-human hybrids.
What do these studies tell us about control of gene expression
in normal, i.e. nonhybrid, cells?

Davis and Adelberg (1973) have

argued convincingly that one cannot draw clean conclusions about
molecular mechanisms from the sorts of results discussed above.
Extinction of melanin synthesis in melanoma-fibroblast hybrids, for
example, might be brought about by dilution of a gene activator
characteristic of melanoma cells, presence of extra repressor in
fibroblast cells, or any of numerous other effects, not all of which
involve transcriptional control of sets of specific genes.
One can, however, draw a few firm conclusions, provided one is
willing to forswear explanation at the molecular level.

The gene dosage

B k - r - - ..
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results suggest that whatever molecules mediate epigenetic status are
not present in very great excess over the concentration required to
exert their influence.

The experiments which demonstrate activation

of the albumin gene in leukocytes and fibroblasts show a) that cells
whose ancestors long ago committed themselves away from hepatic dif
ferentiation have neither lost nor permanently inactivated their liverspecific genes; b) that hepatoma cells not only possess the means to
maintain their own phenotype through mitosis, but also the means to
activate liver-specific genes in at least some other cell types; and
c) that these signals can, at least in some cases, work across species
barriers.

The studies of dissociation, in hybrids, of genes ordinarily

expressed together provide insights into the dependencies of these
genes on one another, and on the hypothetical loci responsible for
co-ordination among the markers which we can measure.

The work on

re-appearance, upon segregation, of extinguished tissue-specific markers
establishes both that these markers can be carried for many generations
in a latent, alert-but-unexpressed state, and that individual chromo
somes can mediate the extinction of genes on other chromosomes, even
across species.

This last result is particularly intriguing:

if

re-appearance of, for example (Weiss and Chaplain, 1971), TAT inducibility truly depends on the loss of a particular chromosome (or set of
hemologues) from the "extinguisher" parent, this suggests that transfer
of "extinguisher" status to the corresponding chromosome in the hepatic
cell's genome does not take place.

Clarification of this important

question will require extension to other sets of hybrids, and, especial
ly, rigorous karyotypic analysis.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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One cannot yet predict the phenotype of hybrid cells from a
knowledge of their parents, although past experience suggests that
such a prediction must take into account gene dosage, and suggests,
perhaps, that aneuploid cells long since selected for vigorous growth
in culture might exert unusual influence over less well-adapted cells.
Cells of a particular epigenetic type (e.g. skin fibroblasts, or
erythrocytes, or blastomeres) might well be unusually able to dominate
intertypic hybrids, or unusually susceptible to influence; but evidence
bearing on this question is so far scant.

PART IB:

Hybridization of thymus cells (and related studies with

thymic leukemias)

Thymus-specific properties have been studied by somatic cell
hybridization in several laboratories, but mouse thymocytes per se
were used in only one of the five reports listed in Table 1-2.
Two reports (Hyman and Xelleher, 1975; Liang and Cohen, 1975)
have shown that when L cells are fused with mouse lymphoid cell lines
which carry the thymus-marker antigen Thy-1, hybrids can be produced
in which Thy-1 is no longer detectable.

In the study of Liang and

Cohen (1975), however, the hybrids were shown to carry another thymic
antigen, Tla.

The L cell line used by Hyman and Kelleher contained

about twice the amount of chromosomal material as did their lymphoma
parent; Liang and Cohen did not report any karyotypic data.
Namba and Waksman (1975) have shown that when rat thymocytes are
fused with mouse lymphoblast cells, the hybrids can retain two thymic
phenotypes: they exhibit a rat thymocyte surface antigen, and produce

Jfcsss-__
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TABLE 1-2
HYBRIDIZATION OF THYMIC CELLS

Authors

Thymic Cell

Other Cell

Result

Parkman et al., 1971

Human thymocyte

"Mouse fibroblast"

Cells produced "human Y~gl°bulin
fragment"

Parkman and Merler, 1973

Mouse thymocyte

clone ID (L cell)

3 clones retain helper activity
no other thymic properties

Hyman and Kelleher, 1975

Mouse lymphoma

A9 (L cell)

All clones Thy-1 negative

Liang and Cohen, 1975

Mouse leukemia

LM(TK ) (L cell)

Clones Thy-1 negative but Tla
positive

Namba and Waksman, 1975

Rat thymocytes

Mouse lymphoblast

Thymocyte antigen and MIF
production
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migration inhibitory factor.

This experiment cannot be considered an

intertypic fusion, since the mouse lymphoblas to id cells are closely
related* developmentally, to thymocytes, but it does provide us with
a control showing that thymus-related phenotypes can survive hybridiza
tion.
The studies of Parkman and his colleagues are most clearly
relevant to my work, but are also most open to question.

Parkman

et al. (1971) state, in abstract form, that human thymocyte x mouse
fibroblast hybrids produce a protein which can be precipitated with
an antiserum to human y-globulin.

"Zero to 60% of colonies" were said

to have been positive upon initial testing.

Acrylamide electrophoretic

analysis of the immunoprecipitate showed that the protein was neither
whole y-globulin, light chain, F . fragment, or F
aw

fragment.

Since

C

thymocytes themselves neither secrete y-globulin nor give rise to cells
that do, it seems likely that the protein produced by these hybrids,
although cross-reactive with y-globulin to some extent, may have had
nothing to do whatever with the lymphoid system.

No controls testing

secretion of this protein by either parent were reported.
Parkman and Merler (1973) later reported, at greater length, the
results of somatic cell fusions between mouse thymocytes (fractionated
into classes of different bouyant densities) and cells of clone ID,
an L cell derivative.

One hybrid clone was tested karyotypically, and

was shown to have 80-95 chromosomes (mouse thymocytes have 40 acro
centric chromosomes, and clone ID 50-55, of which about 20 are bi-armed).
Three of the hybrid clones (it is not clear how many were tested, al
though 27 colonies were isolated) were said to have restored the ability
of irradiated, bone-marrow-reconstituted mice to produce antibody-
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secreting (plaque-forming) cells when challenged with sheep red blood
cells.

The hybrid cells did not display Thy-1 antigen, did not produce

a graft-versus-host reaction when injected into suitably incompatible
mice, did net form spontaneous rosettes with sheep red blood cells,
and grew attached to plastic surfaces.

Taken at face value, these

results suggest that at least one lymphoid function, helper activity,
can be retained in L cell-thymocyte hybrids.
The demonstration of helper activity in these hybrids, though
difficult to explain away, is also quite surprising.

For one thing,

although thymic cells can give rise to T lymphocytes with helper activ
ity, they cannot themselves contribute helper activity to irradiated
hosts.

It is surprising that these hybrids, while retaining one T

cell property, seem to have lost the other morphologic, antigenic,
and functional traits of their lymphoid parent.

The finding that 3

hybrids (out of at most 27 tested) showed helper activity against
sheep red blood cells raises other questions, because the proportion of
T cells reactive against this antigen would be expected to be far lower
than one in nine.

None of the hybrids was found to provide helper

activity against burro red blood cells, or to produce a graft-versushost reaction in allogeneic

mice, although these two antigenic stimuli

would be thought to arouse at least as large a fraction of mouse T cells
as would sheep erythrocytes.

Perhaps sheep-red-cell reactive thymic

cells are more susceptible to fusion than their burro- or alloantigenresponsive neighbors; but it is difficult to see why this should be so.
It is hard to abstract general conclusions from these five studies.
The three studies in which Thy-1
resulted in Thy-1

M

hybrids.

cells were fused with Thy-1+ partners

On the other hand, the work of Liang and

~ —
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Cohen (1975) on Tla antigens and, given the above reservations, the
work of Parkman and his co-^workers, suggest that some of the charac
teristics of thymocytes can be expressed in L cell hybrids.

The

genetic controls on Tla expression are quite complex and not yet well
understood (see Klein, 1975, pp. 241-251); furthermore, the behavior
of the Tla antigens in the hybrids of Liang and Cohen (1975) differs
from that characteristic of these antigens.

Further work is clearly

needed to clarify the fate of thymic phenotypes in thymocyte hybrids.

PART 1C:

Hybridization of Friend erythroleukemic cells

Friend (erythro)leukemia cells (FLC) are near-diploid, tumorigenic,
virus-transformed analogues of proerythroblasts.

Many lines of "Friend

cells" exist, some of independent origin, and some clonally related to
others; it is not clear to what extent variations among the lines
represent different stages of erythroid differentiation "trapped" by
Friend virus transformation.

Most Friend cell lines exhibit some

erythroid properties (e.g. globin mSNA, erythroid antigens, enzymatic
activities).

The most dramatic property of Friend cells is the capacity

of some lines, when treated with dimethylsulfoxide (DMSO), to progress
to a normoblast-like stage.

This maturation involves diminution in

size, changes in enzyme activity, and a large increase in the amount
of both globin mKNA and hemoglobin produced.

The properties of Friend

cells have been recently reviewed (Friend et al., 1974).
Quite a number of cell fusion experiments involving FLC have been
reported.

Orkin et al. (1975) described the properties of hybrids

between two different FLC lines, one of which was better able than the
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other to undergo DMSO-induced maturation.

They found that the hybrids

contained baseline (i.e. uninduced) levels of globin mKNA. comparable
to those of the parent cells, but that DMSO-treatment failed to bring
about much increase in message content.

Similar experiments, although

with slightly different results, have been reported by Paul and Hickey
(1974), and are not directly relevant to our discussion of intertypic
fusion.

These studies do show, however, that fusion itself need not

abolish globin mRNA production, at least at the lower, baseline level,
in FLC.
FLC have also been involved in several intertypic fusions, and
these are summarized in Table 1-3.

Fusion of FLC with 3 different

clones of L cells, or with hepatoma cells, or with SV40-transformed
human fibroblasts, all extinguish globin mRNA production, even if the
hybrid cells are grown in medium supplemented with DMSO.

On the other

hand, fusion between FLC and human marrow cells produces hybrid lines
in which globin mRNA (or globin itself) can be detected after DMSO
treatment.

One interpretation of these results holds that hybrids in

which both parents are already committed to erythroid differentiation
continue to produce globin, but that, for some reason, fusion with
non-erythroid parents blocks production of globin mRNA.

As suggested

by the data in Table 1-3, however, (and shown in greater detail in the
original papers), all those intertypic hybrids in which globin can be
detected have lost the large majority of the chromosomes contributed
by the non-erythroid parent.

All intertypic hybrids in which globin

expression is extinguished have retained large numbers of chromosomes
from both parents.

It would thus be very useful to examine a hybrid

between FLCs and a non-erythroid cell whose chromosomes were lost
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TABLE 1-3
INTERTYPIC FRIEND CELL HYBRIDS

Authors

Other Cell

Chromosome Numbers
FLC
Other
Hybrids

Globin Gene Expression

Orkin et al., 1975

A9 (L cell)

40

50-60

?

extinguished

Deisseroth et al., 1975a

B82 (L cell)

38-39

52

69-105

extinguished

VA2 (SV40-transformed
human fibroblast)

39

74

83-94

extinguished

Human marrow (1°)

38

46

42

mouse

Human marrow (1°)

38
2x 38

46
46

42-44
76-77

mouse; human

38
2x 38

22
22

40
71-83

mouse; CH in

A9

39

54

81-145

extinguished

LM(TK_) (L cell)

37

45

57-75

extinguished

39

59

78-141

extinguished

Deisseroth et al., 1975b

Chinese hamster fetal
erythroblasts

Skoultchi et al^., 1976

Conscience et al, 1976

NOTES:

Hepa-la (hepatoma)

The hybrids tested by Deisseroth et al. (1975b) were uncloned populations; some cells
had received a 2S Friend cell input. Note as well the segregation of human
chromosomes in the primary human marrow fusions. Globin gene expression was tested
by assay of either hemoglobin (for Chinese hamster) or globin mRNA.

%;
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early in the evolution of the hybrid clone.
AT 1 of the cells so far shown to extinguish FLC properties have
not only been non-erythroid, but have been of types whose ancestors
have passed through developmental branches leading away from the
erythroid lineage.

It would be interesting to examine the properties

of FLC hybrids whose other parent, while not committed to red cell
production, had not yet passed through such a branch point:

e.g.

hematocytoblast stem cells or one of the precursors of this cell type.

PART ID:

Terato carcinoma as a model system for the mouse embryo

Nature has contrived serious methodological difficulties for the
mammalian embryologist.

Embryos are small, and are hidden away during

the short period of time in which the developmental "action" takes
place.

Developmental biologists have recently begun to pay attention

to mouse teratomas and teratocarcinomas as accessible models for
embryonic systems, in the hopes that from these tumors they could derive
useful amounts of developmentally-important materials, and could observe
cells going through interesting transitions.

Most research so far has

been aimed at demonstrating the extent to which the model system
imitates the natural one, but a few studies have produced insights into
the surface molecules and viral susceptibilities of teratocarcinoma
cells (and, by inference, of their natural counterparts) that would
have been quite difficult to achieve without the tumor model.
The best review of the early work on mouse teratoma is that of
Stevens (1967a). After his discovery (Stevens and Little, 1954) that
mice of the inbred strain 129 were unusually susceptible to spontaneous

&■■■ ---__
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

16
testicular teratoma, Stevens spent the next two decades studying the
origin of these tumors.

His influential studies (to be discussed

below) produced an apparent paradox whose recent resolution has clari
fied the field considerably (see Damjanov and Solter, 1974, for a
review).
The first well-studied source of mouse teratomas was the genital
ridge of the male fetus.

In ways that are not yet understood, male

primordial germ cells (PGCs) can give rise to embryonal carcinoma cells
(ECCs, the stem cells of teratocarcinomas; see below).

This can occur

either spontaneously, in susceptible strains related to 129, or, in
certain other strains (e.g. A/He; Stevens, 1970a) when the genital
ridge containing the germ cell precursors is
fetus to adult testis.

transplanted from the

That primordial germ cells gave rise to the

tumor cells was suggested on circumstantial and morphologic evidence
by Stevens (1962) and by Pierce and Beals (1964), and confirmed by
Stevens (1967b), who showed that genital ridges homozygous for Sl^
(which, when homozygous, drastically reduces the number of PGCs in
the genital ridge) were incapable of giving rise to teratomas.
Other studies suggested, however, that teratomas could be produced
from embryonic cells at stages during which no PGCs were present.
Stevens (1968, 1970b) showed, for example, that when mouse embryos
from the two-cell to the 6th-day stage were implanted under the testis
capsule of an adult host, the implanted material produced growths which
included a variety of tissue types, sometimes including embryonal
carcinoma cells.

Those tumors which contained a good proportion of the

ECCs were transplantable and were indistinguishable from the transplant
able teratocarcinomas produced from genital-ridge-derived tumors.
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Transplanted embryos could give rise to teratocarcinomas even though
they were of strains (C3H) or sexes (female) whose PGCs were incapable
of producing teratomas spontaneously or through genital ridge trans
plantation.

Histological analysis suggested that the growths were

derived from the transplanted embryonic cells themselves, rather than
from PGCs to which the embryonic cells might hypothetically give rise.
Later work by Stevens and V a m u m (1974) showed that ovarian
teratomas were common in another inbred strain, LT, and that the tumors
in these animals were derived from parthenogenetically-activated
oocytes.

Their careful histologic study showed that activated eggs

underwent an initially normal development, but that disorganization
usually began around the time of "blastocyst" formation, after which
further growth gave rise to typical teratomas, and sometimes terato
carcinomas .
Teratocarcinomas, then, can be derived from primordial germ cells,
from pluripotent embryonic cells in 3-6-day-old fetuses, and from
activated oocytes in females.

Damjanov and Solter (1974) have resolved

these three apparently conflicting results into a convincing picture
of teratoma development whose central tenet is that teratomas develop
whenever "mesectodermal precursor cells" (MPCs) are placed into a
particular kind of "wrong" environment (wrong, that is, for normal
embryogenesis).

They argue that those cells in the egg cylinder which

ordinarily give rise to the ectodermal and mesodermal tissues of the
embryo proper can, in a suitable extra-uterine environment, give rise
to teratomas at very high frequency.

In their view, embryonal carcinoma

cells are (at least early in their history) identical to the mesectodermal precursor cells except that they are misplaced.
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These precursor cells are obviously present in normal 6-day mouse
embryos, and can be produced through normal developmental events from
3-day embryos.

Stevens and Varaua (1974) have shown that activated

LT eggs progress through a series of developmental stages quite
similar to the changes which take place in a normal embryo, sometimes
reaching the primitive-streak stage (7.5 days of gestation), but that
disorganization eventually sets in followed by teratoma formation.
Therefore these partheaotes, too, contain misplaced mesectodermal
precursor cells.
The mechanism by which male primordial germ cells give rise to
teratoma stem cells is less clear.

Stevens, in his examinations of

thousands of early genital-ridge-derived spontaneous and induced
teratomas, has never sear* stages corresponding to mouse cleavage
embryos; the first recognizable teratoma cells resemble those of the
blastocyst inner cell mass (Stevens, 1975).

h’ithcut further investi

gation into the activation process in male PGCs, all one can say is
that such a transition does occur, and that the mesectodermal precursor
cells thus produced, in the absence of their "natural" environmental
signals, give rise to growths which are both disorganized and pro
gressively growing:

i.e., teratomas.

Damjanov and Solter (1974) argue, then, that ECCs (and hence
teratomas) can be produced in any of these three ways, that the cells
produced by the three methods are indistinguishable, and, most radically,
that embryonal carcinoma cells are in no way different from the
mesectodermal precursor cells from which they come.
This last idea has profound implications, and may well be true.
Most tumors are likely to have been derived from cells "transformed" by
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chemical, physical, or viral

agents.

These tumor cells may still bear

stigmata of the transforming agent(viral nucleic acid sequences,

or,

hypothetically, mutations in genes important for growth control), and
their loss of growth control seemsto be irreversible.

If ECCs,

however, are normal although misplaced, the factors responsible for
their tumorigenicity might be very different from those which effect
most other cell types.

ECCs, for example, characteristically retain

near-diploid chromosome numbers (Gurnet, 1974), whereas most other
tumors exhibit more severe aneuploidy.

It is tempting to view these

differences in karyotype as effects of underlying differences in the
ways in which these cells have been rendered tumorigenic.
One important implication of the "normal-but-lost" hypothesis is
that an ECC placed "back" into a blastocyst, in which it will be
exposed to the environment appropriate for normal MPCs, will be able
to regain both growth control and a capacity for normally organized
and properly timed differentiation.

The recent exciting work of

Brinster (1974), ?rn=»ioannou et al. (1975) and Mintz and Illmensee
(1975) suggests that ECCs can indeed act just~ai "2 i£■'■zt.o.dermal precursor
cells if inserted into the blastocyst cavity of normal mouse embryos.

PART IE:

In vitro systems for the study of teratocarcinoma

Tumor cells are often studied in tissue culture for the insights
one can derive into their untransformed analogues, and the preceeding
discussion suggests that ECCs may be unusually good models for the
pluripotent mesectodermal cells of the early mouse embryo.

Further

tests of this assumption will be presented in Part IF, below.

I want

_
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now to discuss the recent work on in vitro culture of teratocarcinomaderived cells, which has made possible experiments not easily carried
out on the tumors themselves.

Gail Martin’s recent review (Martin,

1975) deals largely with these cultures and is essential reading for
newcomers to this field.
Figure 1-1 shows the relationships among the different kinds of
teratocarcinoma-derived cell cultures and the tumor forms from which
they come.

Teratocarcinomas, whether embryo-derived, spontaneous

(testicular or ovarian), or produced by genital-ridge transplantation,
are usually maintained by repeated subcutaneous passage in histocompatible mice.

Some tumors have also been converted into an unusual

ascitic form, in which clusters of cells, called "embryoid bodies"
(Stevens, 1959; Pierce and Dixon, 1959), usually containing a central
core of ECCs surrounded by primary endoderm cells together with varying
amounts of other cell types, grow free in the peritoneal fluid.
Embryoid bodies are maintained by injection of infected ascitic fluid
into successive host animals.

Embryoid bodies can also produce solid

growths, with the usual chaotic pattern of embryonal carcinoma
differentiated tissues, either after implantation on the peritoneal
wall after intraperitoiteu-L- inoculation, or if a suspension of embryoid
bodies is injected subcutaneously.

‘

—

Cell cultures can be initiated from either subcutaneous tumors or
embryoid bodies.

These primary cultures contain varying proportions of

ECCs and differentiated elements, among which primary endoderm is
usually predominant at first.

By the time a primary culture is suf

ficiently well established to permit subculture, much cell death has occurred,
possibly involving selection for those cells best adapted to growth

- ______
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Figure 1-1

Derivations of teratocarcinoma cell lines and tumors.
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in vitro.

These initial populations can be subcultured repeatedly as

mixtures composed of ECCs, their newly-differentiated derivatives,
and the mitotic progeny of those differentiated cells which can still
divide.

The work of Lehman et al. (1974), Gearhart and Mintz (1974),

Levine e£ al. (1974) and Teresky et al. (1974) has shown that these
primary and secondary cultures can be used to follow morphological
and biochemical differentiation of teratocarcinoma cells in culture.
There are a number of ways in which less heterogeneous cell lines
can be derived from such a mixed culture.

The earliest reports of

teratoma-derived cultures (Finch and Ephrussi, 1967; Rosenthal et al.,
1970; Kahan and Ephrussi, 1970) showed that cloning of cells from
mixed cultures failed to abolish pluripotency.

Cloned cells were able

to give rise not only to multi-differentiated tumors, but also to
morphologically heterogeneous culture populations.

By subculturing

from mixed populations in such a way as to favor transfer of the ECCs,
which attach only loosely to plastic surfaces, one can maintain a
population which is made up predominantly of pluripotent cells, but in
which contamination with freshly differentiating cell types repeatedly
takes place (e.g. Lehman et al., 1974).

The SIKR line used by Jami

et al. (1973) for cell fusion experiments has been shown to be a
"mixed clone" of this sort (Martin and Evans, 1974).
Teratocarcinoma-derived cell lines in which pluripotent cells are
no longer present also exist.

Many of these seem to consist of fibro-

blastoid cells not easy to classify further.

More interesting

"monopotent" lines have, however, been produced.

Boon jit al. (1974)

nave derived fvo lines of myoblastoid cells by mechanical isolation
of beating foci found in a mixed culture.

Rheinwald and Green (1975)
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isolated a line of keratinocytes from a mixed culture in two stages:
first, the mixed population was propagated under conditions which
favored the growth of epithelial cells, after which the population
was cloned and a well-differentiated colony picked for further study.
Mixed cultures can also convert to nonpluripotent cultures simply by
overgrowth of a differentiated cell type which divides more rapidly
than the ECCs under the culture conditions used.
Several laboratories have been able to isolate cell lines which
seem, at least on morphologic grounds, to consist only of embryonal
carcinoma cells.

Jakob et al. (1973) have, for example, isolated

several of these lines, including a clone called PCC4azal, the
azaguanine-resistant derivative of clone PCC4 which was used in the
experiments I have carried out and will discuss below.

It is not

clear why the lines isolated by this group show so little tendency
to differentiate in logarithmic cultures, since Jakob et al. (1973)
used the same techniques (cloning and selective subculture) which in
other hands produced "mixed clones" partially contaminated with
freshly differentiating cell types.

These "pure" ECC lines usually

retain the ability to produce multi-differentiated tumors, but only
some of them (Nicolas et al., 1975) are able to differentiate in
tissue culture, and then only under particular culture conditions.
PCC4azal, the cell line used in my work, is able to differentiate
in vivo (Jakob et al., 1973) and after special manipulations in vitro
(Sherman, 1975a), but appears to consist entirely of ECCs under
routine culture conditions.
Some ECC lines, after many months of growth in vitro, are found
tc h=*^e lost the ability to differentiate in tumors, although they
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resemble the pluripotent ECC lines in feeir other characteristics.
These cell lines are said to he "nullipotent".

F9 is the best studied

line of this type; it was isolated by Granachamp
first mentioned in Bemstine et al. (1973).

and Ephrussi but

Recent work (Sherman and

Miller, in preparation) suggests that F9 cells are able to produce
parietal yolk sac endoderm, under special growth conditions in vitro,
and as small, scattered nodules in tumors, but seem to be unable to
generate other kinds of differentiated cells.
Martin and Evans (1975a, b, c) have recently developed a method
for isolating pure lines of ECCs which seems likely to supplant the
other methods used in earlier work.

Their procedure involves the

mechanical removal, from primary or secondary mixed cultures, of
single embryonal carcinoma cells under the dissecting microscope.
These isolated cells are then cloned on fibroblast monolayers.

Martin

and Evans postulate (1975a) that unselected ECCs require some product
of the "feeder" fibroblasts.

In their view, previous attempts to

isolate pure ECC lines without the use of feeder layers may have
failed because of selection for ECCs which continually gave off the
fibroblastoid derivatives they needed to provide a feeder monolayer.
The success of the Paris group (Jakob et al., 1973) in isolating
apparently pure ECC lines without feeders may have been due to growth
conditions which selected for feeder-independent cells; it is not
clear to what extent this selection may have modified the other
properties of the pluripotent Parisian lines.

Using their single cell

cloning technique, Martin and Evans have repeatedly obtained, at about
40% cloning efficiency, lines of ECCs which, when kept on feeder layers,
show little tendency to produce differentiated offspring.

This group
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has also defined conditions (Martin and Evans, 1975a, b, c) under
which their cell lines can be induced to differentiate.

Under some

regimens, differentiation begins with the formation, in culture, of
structures much like embryoid bodies.

This system seems to furnish an

excellent in vitro model for two of the earliest determinative
transitions of the mouse embryo:

formation of primary endoderm from

the "embryoblast" cells of the inner cell mass, and the (endoderminduced?) formation of mesodermal derivatives from the remaining MPCs.
The fidelity with which the differentiating cultures of Martin and
Evans mimic the early stages of ontogeny reinforces our conviction that
ECCs are good models of embryonic mesectodermal precursor cells.
We will test this faith further in the next section, devoted to
the properties of the embryonal carcinoma cell.

PART IF:

Properties of embryonal carcinoma cells

My aim in discussing the properties of embryonal carcinoma cells
is twofold:

both to show by what tests these cells can be distinguished

from other kinds (e.g. other parents in a hybridization experiment, or
other cell types in a mixed culture) and to test further the claim
that ECCs resemble closely the mesectodermal precursor cells in the
normal mouse embryo.

Developmental properties.

The important developmental properties of ECCs are two:
cells are pluripotent, and they are tumorigenic.

these

The pluripotency of
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individual (i.e. cloned) ECCs has been demonstrated in vivo by
Kleinsmith and Pierce (1964), and in vitro by Finch and Ephrussi
(1967) and by Rosenthal et al. (1970).

ECCs are thought to confer

transplantability on teratocarcinomas (see Damjanov and Solter, 1974,
for a discussion), because the capacity of a tumor to survive trans
plantation seems to be dependent on the presence of morphologically
recognizable ECCs within it.

Although Kleinsmith and Pierce (1964)

were able to obtain tumors at a low rate (43 tumors from 1790 animals
4
inoculated) by injection of single ECCs, doses of 10 cells/animal are
usually necessary to produce tumors in most of the injected mice
(Jakob et al., 1973).

Boon et al. (1975) have described the production

of non-ttimorigenic lines from mutagenized ECC cultures.
MPCs are, of course, also pluripotent.

The work of Solter and

Damjanov (1973) suggests that for a transplanted embryo to give rise
to a tumor, it is necessary that the MPC-containing half of the egg
cylinder be included in the graft.

Over 50% of transplanted embryos,

earlier than 8 days of gestation, produce teratomas, of which about
half contain ECCs and are thus likely to be teratocarcinomas (Stevens,
1970b; Solter et al., 1975). This high rate of tumor formation suggests
that at least some of the MPCs in the 2-7-day-old mouse embryo are
capable of producing transplantable tumors if placed into the right
environment, even in the absence of carcinogenic treatment.
The discovery of Sobis and Vandeputte (1975) that benign teratomas
could be produced in rats by displacement of visceral yolk sac endoderm
to the outside of the uterus (with fetectomy) suggests that MPCs may
not be the only pluripotent cells in the early post-implantation embryo.
These rat tumors, however, contain no embryonal carcinoma cells and are
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not tumorigenic; they therefore furnish no evidence against the claim
that MPCs are the cells which give rise to ECCs in the mouse systems
under discussion.

Mbrphological properties.

ECCs, however derived, have a characteristic ultrastructure; the
most recent review is that of Damjanov and Solter (1975) .

In tumors

and in culture, these cells typically exhibit the following features:
a high ratio of nuclear volume to cytoplasmic volume (compared to most
well-differentiated cells) ; a prominent, usually single nucleolus,
centrally located in a nuclexis with little other condensed chromatin;
and a cytoplasm which contains many free ribosomes but few other
organelles— mitochondria are present but scarce.

The ultrastructure

of these cells is very similar to that of both primordial germ cells
in the male (Pierce and Beals, 1964) and mesectodermal precursor cells
(Damjanov et al., 1971a).

Taken together, these structural elements

combine to produce a phase contrast image (see below) of these cells
which one can, with a little experience, learn to recognize easily,
and which is easy to distinguish from that of most other cell lines.
Cells cultured from the inner cell mass of mouse blastocysts strikingly
resemble teratocarcinoma-derived ECCs (see figure 1 in Sherman, 1975b,
for a photographic comparison). Paulin et al. (1976) have described
ECC-specific patterns of non-histone chromatin protein and soluble
nuclear protein which may contribute to the unusual nuclear structure
(not to say developmental properties!) of these cells.
ECCs in culture also exhibit a characteristic growth habit:
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subculture, even from a single-cell suspension, they tend to attach in
clumps, from which the individual cells show little tendency to
migrate.

ECCs in some lines grow as mounds of cells more firmly

attached to one another than to the substrate.

This colonial behavior

in culture may be a reflection of the tendency of ECCs in tumors to
form islands of cells surrounded by streams of differentiated cell
types.

Alkaline phosphatase.

Alkaline phosphatase (APase; E.C. 3.1.3.1), an enzyme demonstrable
by its hydrolysis of phosphate esters at alkaline pH, but whose role
in cellular metabolism is not understood, is present in large amounts
in a number of somatic tissues (bone, intestine, kidney, liver,
placenta, white blood cells; see Kaplan, 1972, for a useful review).
Although APase is not present in high levels in most cultured cell
lines or in most cell types in the early embryo, high specific activi
ties can be demonstrated in ECCs both in tumors (Damjanov et al.,
1971b) and in culture (Bernstine et_ al., 1973).

The demonstration that

MFCs, alone among the cells of the mouse egg cylinder, have high APase
levels (Solter eit al., 1973) supports the contention that these cells
are the normal counterparts of the ECC.

APase is also present in high

specific activity in primordial germ cells (Chiquoine, 1954).

Those

non-pluripotent cell lines derived from teratocarcinoma which have been
tested for APase, like most differentiated tissues in teratocarcinoma
tumors, have proven to have little activity (Bernstine et al., 1973).
Thus, this enzyme serves as a useful marker for the ECC, and its loss,
a useful though by no means infallible marker for ECC differentiation.
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Response to viruses.

Tollman anH his co-workers have tested the response of cultured
ECCs to several mammalian viruses, in the hopes that if differences
could be found between ECCs and other cultured cells in their response
to virus infection, these differences might provide insights into viral
metabolism and into the pluripotent state.

Swartzendruber and Lehman

(1975) showed that SV40, although able to bring about T-antigen
synthesis in abortively-infected non-pluripotent mouse cells, was
unable to produce this antige:: in ECCs.
SV40 met with failure.

Attempts to transform ECCs with

Differentiated cells present in mixed cultures,

however, were able to make both T and V antigens, and were found to be
susceptible to SV40 transformation.

Similar results were obtained

with another oncogenic DNA virus, polyoma; only the non-pluripotent
cells were able to produce polyoma T and V antigens, and made infectious
virus as well.

(Most mouse cells are permissive for polyoma, br*-

support only abortive infection, with occasional transformation, by
SV40.)

In a second paper, Lehman et al. (1975) demonstrated that ECCs

were also resistant to infectious SV40 DNA, suggesting that resistance
is dependent on some event subsequent
Lehman et al. (1975) also showed that an

toviral attachment and

unpacking.

unrelated RNA virus, mengo-

virus, is_ able to replicate in ECCs, but that virus yield is much
reduced.

Jaenisch and Mintz (1974) have shown that exposure of pre

implantation mouse embryos to SV40 virus can lead to the production of
adult mice whose cell nuclei contain SV40 nucleic acid sequences, but
one cannot deduce from their data the cell type or embryonic stage at
which the viral information was introduced.

.
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Miller et al. (1976; submitted for publication) have shown that
ECCs are resistant to infection by a mouse parvovirus, MVM; some of
these results will be presented below.
The resistance of ECCs to a number of viruses which do infect
non-pluripotent mouse cell lines is relevant here largely as a way to
distinguish ECCs from other cell types.

It seems likely, though, that

further study of these phenomena will give us insights into viral
metabolism, and into changes in the intracellular milieu during early
embryogenesis.

Surface antigens.

Studies of the surface antigens of ECCs have provided, in addition
to useful markers for these pluripotent cells, new perspectives on the
genetic control of surface molecules and the role of these molecules
in ontogeny.
The initial paper in a series of influential collaborative reports
was that of Artzt et al. (1973).

These workers showed that when 129/Sv

mice were inoculated with cells of a syngeneic "nullipotent" embryonal
carcinoma cell line, F9, they produced hyperimmune serum cytotoxic for
F9 cells.

A series of direct cytotoxic tests and absorptions showed

that the sera detected antigens present on all tested ECC lines, but
not present on any of the many non-pluripotent lines tested, including
some also derived from 129/Sv teratocarcinomas.

These "F9" antigens

were not found on thymus cells, but were detected on spermatozoa and
cells in testis suspensions.

Immunoperoxidase labelling showed that

cross-reacting (and possibly identical) antigens were present on

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32
cleavage-stage mouse embryos.
By using syngeneic cells for immunization, Artzt and her collab
orators hoped to have manufactured a serum which detected only those
surface antigens which, though present in early embryos and their
teratoma-derived analogues, had disappeared from the embryo by the
time self-tolerance was initiated.

(It is not surprising that sperm

might prove to be an exception, since male germ cells are inaccessible
to cells of the immune system and can give rise to potent autoanti
bodies if inoculated around this "blood-testis barrier.")

The

demonstration of antigens common to embryonal carcinoma cells and early
mouse embryos supported the growing conviction that these cell lines
were good models for early embryonic cells.
In a second paper, Artzt et al. (1974) showed that spermatozoa
could absorb anti-F9 cytotoxic activity (as measured with F9 target
cells) to a degree that depended on their genotype.

Sperm from an

12

animal which was heterozygous for the mutant allele t

(at the complex

T/t locus) were only half as effective in removing anti-F9 cytotoxic
activity as sperm from an animal homozygous for the wild-type allele,
+

tl2

.

They concluded that the F9 antigen was probably specified by

the wild-type allele.
The T/t complex comprises a series of interacting loci with
effects on early embryonic morphogenesis, sperm structure and function,
and recombination in the chromosome segment stretching at least from
the T locus to the H-2 complex 13.5 centimorgans distal on chromosome
17.

Three useful reviews (Gluecksohn-Waelsch and Erickson, 1970;

Bennett, 1S75; and Klein, 1975, pp. 251-274) are available to acquaint
the novice with the large amount of work which has been done on this
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most mysterious and fascinating of mammalian complex loci.

The work

of Bennett et al. (1972) had suggested that the effects of T/t locus
mutants on spermatozoa might be mediated by surface molecules.

The

work of Artzt et al. (1974) just discussed showed that the effects of
these genes on embryonic development might also involve surface
antigens, and that these molecules could be studied using the terato
carcinoma model systems.

There are several complementation groups

of recessive-lethal T/t locus mutants; members of a particular group
block embryogenesis at a group-specific stage.

12

t

The group including

(the wild-type allele of which had been associated with F9 antigen)

blocks embryogenesis at a very early stage:

12

homozygous t

are unable to proceed from morula to blastocyst.

/t

12

embryos

The demonstration

that F9 antigen was present on late cleavage stage embryos was seen
by Artzt et al. (1974) as consistent with the idea that this surface
molecule is necessary for the -transition to blastocyst, and consistent
with the notion that ECCs are analogous to morula cells.
A third paper (Vitetta et al., 1975) showed that F9 antigen,
isolated from other surface molecules by immunoprecipitation, shared
certain biochemical properties with H-2 antigens.

Artzt and Jacob

(1974) showed, around the same time, that F9 cells lacked H-2 antigen,
at least insofar as could be demonstrated by cytotoxic absorption
tests.

They suggested that the F9 antigen might take the place of

H-2 on early embryonic cells and ECCs.
The idea had been growing for some time that the association, on
chromosome 17, of these two most fascinating and mysterious of
mammalian complex loci had better be explained.

(The current basis

for this suspicion is reviewed in Artzt and Bennett, 1975.)

The
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linkage disequilibrium discovered by Hammerberg and Klein (1975)
between the two complexes further suggests that the similarities and
linkage between these sets of loci may be more than just a historical
accident.

Biochemical studies of the F9 antigen are still in their

preliminary stages.

The smaller of the

F9 polypeptides is not

immunologically cross-reactive with mouse g-2-microglobulin, its
counterpart in the H-2 molecule (F. Jacob, personal communication).
Work to compare the amino acid sequence of the F9 and H-2 molecules
is in progress.

The identity of the H-2-associated molecule(s) which

interact with products of the T/t locus, and the nature and value of
this interaction are still entirely unknown.
These studies lead to a neat model of surface antigen progression
tl2
in developing embryos, in which F9 (+
) antigen appears before the
morula stage, somehow assists in the morula-to-blastocyst transition,
and is eventually replaced by H-2 molecules.

The products of the

other T/t loci might well follow similar schedules at appropriate times
and in appropriate cell types.

There are, however, a number of

findings which, while not inconsistent with this model, suggest that
the model may be too simple.

For one thing, F9 antigen is present in

mesectodermal precursor cells in mouse embryos at least as late as the
egg cylinder stage (L. Stevens and F. Jacob, personal communication),
as well as on ECCs derived from embryos more mature than blastocysts.
Similarly, H-2 antigen is thought not to appear in the mouse embryo
until 7 days after fertilization (see Billington and Jenkinson, 1975).
It is clear, then, that the postulated replacement of F9 antigen by
H-2 does not occur until long after the stage at which the +

tl2

gene

is known to act (the morula-to-blastocyst transition occurs on the 4th
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day after fertilization.)

Furthermore, although no one has yet found

an ECC which lacks F9 antigen, there are several non-pluripotent lines
which express antigens which can be recognized by aati-F9 serum in
immunofluorescent assays (my unpublished results and Artzt, personal
communication.)

Furthermore, a similar anti-ECC serum produced by

S tem et al. (1975) can be absorbed successfully, not only by ECCs,
but by mouse brain and kidney as well.

Although this 129-anti-SIKR

serum was produced by a protocol similar to that used for anti-F9
serum, and has a similar spectrum of reactivity (including ECCs, sperm,
and morulae), it is not clear whether the product is recognizes is the
"F9" antigen, or is even specified by a gene at the T/t complex.

Stem

et al. (1975) characterized their serum by immunofluorescent assays,
whereas Artzt and her colleagues use cytotoxic tests; it is not clear
whether the sets of teratocarcinoma-specific antigens detected by
these two methods are identical.
S t e m e± al. (1975) also looked for the presence of H-2 and Thy-1
antigens on ECCs and their differentiated progeny.

They confirmed the

result of Artzt and Jacob (1974), mentioned above, that ECCs lack H-2,
and found that Thy-1 antigen was also undetectable, but that both
antigens were present in ECC-derived cultures containing large numbers
of differentiated cells.

The earliest of the differentiated cell

types produced in their system (primary endoderm) was, however, devoid
of all three antigens:

H-2, Thy-1, and the ECC antigen detected by

their anti-SIKR serum.
To sum up:

embryonal carcinoma cells seem to lack the H-2 antigens

found on most other cell types, and to possess their own surface
antigens missing on most cells of later embryonic and adult stages.
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similar antigenic repertoire is characteristic of mouse morulae, and
possibly of the mesectodermal precursor cells of the egg cylinder as
well.

PART 1G:

Somatic cell hybridization of teratocarcinomas

Besides the work to be described in this thesis, there have been
five reports, two of them preliminary, of hybridization between
cultured teratocarcinomas and other, non-pluripotent cell types.
In the earliest of these, Finch and Ephrussi (1967) fused a line
of feeder-cloned, 402 AIII embryoid-body-derived cells, shown to be
able to produce multi-differentiated tumors, with either of two mouse
fibrosarcomas:

LM(TK ) clone ID, or 2472-6-3, a clone of Sanford's

"high cancer" line NCTC 2472.

The teratoma-derived parent, called

clone 8, was said to yield cultures "homogeneous in appearance," but
the published photograph shows, at the top, cells which seem inter
mediate in morphology between ECCs (which make up most of the colony
shown) and the epithelial cell types which often appear in "mixed
clone" cultures.

The fibroblast cells each carried an enzyme deficiency

preventing growth in the selective HAT medium, but the teratoma line
carried no selectable marker.

Hybrids were produced by mixing the two

parental cell types without addition of Sendai virus.

HAT medium was

used to kill the fibroblast parent, and colonies of putative hybrids
were picked for further analysis because they were "distinguishable
from teratoma cells morphologically and by their higher growth rate."
Each of the three parents used in these experiments carried at least
one marker chromosome not found in the other cells, and karyotypic
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analysis showed that the picked colonies were in fact made up of
hybrid cells.

Seven of the hybrid clones were shown to produce tumors

indistinguishable histologically from the fibrosarcomas formed after
inoculation of LM(TK~) or 2472-6-3.

There was no evidence of either

embryonal carcinoma cells or differentiated elements (besides fibro
blasts) in the hybrid tumors.
A very similar study has been reported by Jami et al. (1973).
This group produced and studied hybrids between LM(TK ) clone ID and
a "mixed done" teratocarcinoma SIKR (Evans, 1972; Martin and Evans,
1974).

Hybrids were produced with the help of Sendai virus, the

fibroblast parent killed with HAT, and "hybrid colonies...identified
by their cell morphology which is distinct from SIKR colonies."
Karyologic analysis showed that the two hybrids isolated had more than
98% of the "expected" chromosome number for a 1:1 fusion product
between the two parents.

The hybrid cells formed tumors in (129 x

CS^F^ mice but not in 129 or C3H animals, suggesting that they re
tained at least some of the histocompatibility genes of both parental
cells.

Isozyme analysis showed that in those instances where the two

parental cells differed in their proportions of a particular isozymic
form, the hybrid pattern resembled that of LM(TK ) .

In particular,

"two faster molecular forms of lactate-dehydrogenases were found in
SIKR" (presumably LDH A^B^ and A^B^; see below) and were absent both
in clone ID and in the hybrids.

The hybrids formed tumors in

mice

which, like those of the fibroblast parent, contained only fibrosarcomatous tissue, devoid of either embryonal carcinoma or any of the
variety of differentiated cell types found in SIKR tumors.

When cell

lines were initiated from some of the tumors, 4 of the 5 lines derived
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were found to have retained more than 94% of the chromosome number
characteristic of the inoculated cells; the other tumor had lost 25%
of the original number.
A report by McBurney (1976), which deals largely with the isolation
and characterization of several ECC lines, mentions hybridizations
between two of these lines (0C15 and OC49) and cells of the established,
subtetraploid, non-tumorigenic mouse fibroblast line, 3T3.
resistant, TK

A ouabain-

variant of 3T3 was used, and ouabain employed to select

against the ECClines.
hybrid colonies

The 3T3 cells were killed in

HAT.

All the

were fibroblastic in morphology and, like their 3T3

parent, contact-inhibited for growth.

0C49 is a near-tetraploid ECC

line, and contains more chromosomes than the 3T3 line used; 3T3 x 0C49
hybrids were also fibroblastoid.

The hybrid cells were not able to

form tumors (probably because the 3T3 parents originated in an outbred
strain of mice) but, when cultured under conditions which promote
differentiation

of the ECC parental cells, gave rise only to fibro

blastoid cells.

McBurney (1976) has also shown that forcing ECCs to

become tetraploid by treatment with cytochalasin B (a drug which permits
nuclear division but blocks cytokinesis) does not entail a loss of
pluripotency.

Loss of pluripotency in some kinds of teratocarcinoma

hybrid cells cannot therefore be attributed simply to increased
chromosome number.
If taken at face value, these results suggest that hybrids between
a pluripotent cell, such as those which predominate in the terato
carcinoma cultures used for the fusions, and a differentiated fibroblast
cell can resemble the non-pluripotent parent.

A more detailed criticism

of this conclusion will be reserved for later.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

39
Two further (and preliminary) accounts of fusions involving
teratocarcinoma cell lines have appeared in print.

Evans (1975)

mentions the unpublished thesis research of his student, K. Sit, who
produced two series of hybrids between SIKR and differentiated parents.
Two clones of hybrids between SIKR and A9 (a mouse fibroblast closely
related to LM(TK~)) are said to have produced only fibrosarcomatous
tumors, in agreement with the results mentioned above.

A series of

8 hybrid clones between SIKR and N86, a mouse neuroblastoma derived
from the A/J C1300 tumor, are said also to have given rise to fibro
sarcomatous tu m o rs without evidence of neural tissue.

In culture,

however, these hybrids are said to have had a high content of mono
amines, which are characteristic of the neuroblastoma parent, but not
of SIKR.

Both series of hybrids were apparently isolated without

biochemical selection against the SIKR parent; i.e., hybrid colonies
may have been chosen for study on morphological criteria.
A control series of "self-hybrids" (SIKR x SIKR) was created by
mixing SIKR cells with Sendai virus and picking "colonies of polyploid
cells, which could be recognized by their greater size."

These

putative hybrids, with modal chromosome numbers ranging from 71 to 143
(SIKR mode is 41), were said to produce fibrosarcomas.

Evans suggests

that this surprising result could have come about in one of two ways:
a) fusion itself might be able to bring about restrictions of the
hybrids' developmental potential, or b) the fibroblastic cells known to
contaminate SIKR cultures might be especially susceptible to Sendaimediated fusion.
Another series of teratocarcinoma hybrids has been constructed by
Bernstine and Ephrussi (1975) and reported in preliminary form.
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cell i-fnps are the product of fusion between a neuroblastoma line
(N18TG2, a close relative of the line used by Sit and Evans) and
H3.6, described only as an "embryonal carcinoma line" with high
alkaline phosphatase activity.

The emphasis in this report is on

the APase activities in the hybrids.

The ECC parent has 18-fold more

activity than the neuroblastoma parent, but hybrids have from 1.1to 7.6-fold more APase than even the ECC parent.

A portion of this

increase may be due to changes in the response to growth inhibition
in crowded cultures, in that Bernstine and his co-workers have
shown that APase can increase at confluence as much as two-fold in
ECCs.

It will be important to learn whether the APase activity in

the hybrids is like that of the ECC or of the neuroblastoma, since
related clones of N18 neuroblastoma cells have very high APase
activity (my unpublished results).

Bernstine's preliminary results

using heat denaturation kinetics suggest that the enzyme in the
hybrids resembles that of the ECC parent, but more work is needed.
The report of Bernstine and Ephrussi (1975) contains very little
information about what their hybrid cells look like.

One clone, NT3,

is said to make up a "homogeneous population of fibroblastic cells."
The other two primary clones, NT1 and NT2, are said to exhibit
morphological heterogeneity in vitro.

Subclones of homogeneous type

have been derived from the more heterogeneous primary clones.

Tumors

derived from NT1 and NT2, and from their subclones, are said to have
been composed of "one predominant cell type" without "organized
structure"; "differences between tumors produced by various clones
have been noted."

One cannot tell from these hints whether these

hybrid cultures and tumors contained ECCs, neural elements, fibroblasts,

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

41
or perhaps other kinds of differentiated cells.
Jami and Loeb (1975) have mentioned unpublished work of Jami and
Diacumakos to the effect that neuroblastoma x teratoma hybrids re
semble neuroblastomas.
In summary, then:

No details are given.
there is as yet no good evidence that terato-

carcinoma-derived hybrid cells can retain pluripotency, although the
hybrid lines of Bernstine and Ephrussi (1975) may, when reported in
more detail, retain some of the properties of ECCs.

Three sets of

hybrids between teratocarcinoma lines and mouse fibroblasts have
resembled their fibroblast parents, although it is difficult in some
cases to know whether the hybrid actually involved an embryonal
carcinoma cell.

In all these studies, except the case of McBumey's

(1976) 0C49 x 3T3 hybrid, the non-teratoma parent initially contributed
more chromosomes to the hybrid cells than the teratoma-derived parent,
so that controls to study the effect of more nearly equal gene dosage
would be useful.

PART 1H:

Production of a-fetoprotein in teratomas

a-fetoprotein (AFP) is a glycoprotein of molecular weight 68,000
found in high concentrations in amniotic fluid and the serum of third
trimester mammalian embryos, but which is not present in the sera of
normal (nongravid) adults.

Certain differentiated tumors secrete AFP,

most notably hepatomas and teratomas, so that detection of this
substance has become a useful tool in the management of patients with
these diseases.

Abelev (1974) has written a fine review of AFP as a

marker of embryo-specific differentiation in tumors and in normal
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embryos.

A minor controversy has arisen over the question of which

cells in a teratocarcinoma produce AFP, and it is the purpose of this
brief section to come down on one side of the controversy.
In the normal embryo, AFP synthesis occurs in the yolk sac
endodert., and later in the liver (Gitlin and Boesman, 1967; Gitlin
et al., 1972).

Using an immunofluorescent technique, Engelhardt

et al. (1973) showed convincingly that AFP in mouse teratocarcinomas
was, not surprisingly, associated almost entirely with endodermal
derivatives:

visceral yolk sac endoderm, and epithelia lining glands

and tubules.

Further supportive evidence for the proposition that

AFP is a product of differentiated endodermal cells is summarized by
Abelev (1974).

Embryonal carcinoma was present in the tumors analyzed

by Engelhardt et al. (1973), and was found not to be associated with
AFP-specific fluorescence.
The work of Kahan and Levine (1971), however, had suggested that
ECCs did produce AFP.
evidence.

Their conclusion was based on two pieces of

In the first place, they found a "serum a-l-protein" in

mice carrying transplantable teratocarcinomas (which contain ECC),
but not in those with "well-differentiated" primary teratomas (which
do not).
given.

The amount of endoderm in these tumors was not, however,
More significantly, a cloned cell line, T ^ 8-10, consisting

in vitro of a "compact monolayer of undifferentiated epithelial cells",
and which gave rise to tumors consisting almost entirely of embryonal
carcinoma with sparse parietal yolk sac, was shown to produce this
a-1 protein, in vitro and in tumors.
On the whole, the evidence strongly supports the idea that AFP in
teratocarcinomas originates in endodermal cells.

If the protein
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studied by Kahan and Ephrussi was in fact AFP, its production by the
poorly-differentiating line T17 8-10 is surprising.

It is possible

that this line might not be an ECC line at all, but rather a poorly
differentiated parietal yolk sac carcinoma (no photographs are shown);
another possibility is that

8-10 represents a rare variety of ECC

which has acquired the capacity to produce AFP.

The immunohistological

studies of Engelhardt et al. (1973) show clearly that when embryonal
carcinoma and visceral yolk sac endoderm are both present in a terato
carcinoma, only the latter contains detectable AFP.

My work (to be

reported below) is quite consistent with this conclusion.

PART II:

Experimental strategy.

The work reported in this dissertation concerns the production
and characterization of two series of somatic cell hybrids.

The PCT

hybrids are the products of fusion between cells of a pluripotent
embryonal carcinoma line, PCC4azal, and normal mouse thymocytes.

The

PCF hybrids result from fusions between PCC4azal and a line, FBU, of
Friend erythroblastic leukemia cells.

The purpose of this section is

to show that these particular hybrid series could help to clarify some
of the issues discussed above.
Nearly all the intertypic hybrids previously studied have involved
non-pluripotent, "differentiated" parental lines, whose cells contain
molecular machinery responsible for the maintenance of a particular
epigenetic state throughout the cell cycle and through mitosis.

The

eventual phenotype of the hybrid cells, therefore, reflects the con
flicts and compatibilities between two different sets of stabilizing

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

44
influences. ECCs, though phenotypically stable under some conditions,
must contain a molecular apparatus, not present in most other cells,
which permits the ECCs to generate the entire diverse repertoire of
stable, "mature" epigenetic states.
It is not easy to predict the phenotype of a fusion product, one
(and only one) of whose parents is able to produce, through normal
developmental events, cells much like those of the other parental line.
One might argue that (e.g.) the PCF hybrids ought to resemble the
differentiated Friend cell parent, since a) the Friend cell is known
to produce molecules which can impose an erythroid "set" on newly
synthesized mouse haploid genomes; and b) PCC4azal is known to contain
a genome in such a state that it can, under conditions that occur in
normal development, adopt such an erythroid "set".

The findings of

Finch and Ephrussi (1967) and of Jami et al. (1973), which showed that
teratoma-fibroblast hybrids are fibroblastoid, support this prediction.
On the other hand, the "signals" which Friend cells employ to
insure the erythroid nature of their mitotic progeny are very likely
to be distinct from those to which erythroid-bound pluripotent genomes
are exposed.

Pluripotent cells must ordinarily progress through a

number of stages, starting with the hematocytoblast or its earliest
precursor, before giving rise to the basophilic erythroblasts which
the Friend cells (Conscience et al., submitted for publication) mimic.
Even if the ECC genome were responsive to the molecules which Friend
cells use to maintain their epigenetic state, it is not certain that
these influences would survive the "unnatural" early stages of hybrid
formation.

Indeed, the experiments (reviewed in Gurdon, 1974) which

have shown that pluripotent amphibian oocytes can "reset" the genomes
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of differentiated nuclei inserted into oocyte cytoplasm hint that
mammalian pluripotent cells, too, might perhaps be able to abrogate
the epigenetic set of a mature differentiated cell.
As discussed above, several hybrid clones between teratoma-derived
cells and fibroblasts have been reported; in general, these hybrids
have resembled their fibroblast parents.

PCT and PCF hybrids provide

especially favorable material to test the generality of the notion
that hybridization of ECCs destroys their pluripotency.

For one thing,

PCC4azal, FBU, and thymocytes all contain 39-40 chromosomes (and 4043 chromosome arms); thus, considerations of gene dosage ought to play
less of a role in these hybrids than in hybrids whose fibroblast parent
contained 50-55 chromosomes (and roughly 55-65 chromosome arms).
Perhaps more significantly, the genomes of PCC4azal and FBU (and, of
course, normal thymocytes) closely resemble those of normal mouse
cells.

Aneuploid fibroblast cultures continually undergo karyotypic

modification (Ailerdice et al., 1973; Hashmi et al., 1974), so much
so that of 11 A9 cells analyzed in the former paper, "no two cells
had the same chromosome content."

ECC cultures, in

contrast, are

remarkably stable (McBurney, 1976), and undergo little change in either
chromosome number or morphology upon continued passage.

Friend cells

have not been so extensively analyzed, but their stable, near-diploid
chromosome number and low content of bi-armed chromosomes suggest
that they, too, resemble normal cells genetically.

The rapid karyo

typic evolution of most aneuploid cultures may well have facilitated
selection for cells well adapted to growth in vitro, but may in the
process have produced cells differing from normal ones in ways important
to epigenetic mechanisms.

It is important that developmental lessons
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drawn from studies of hybrids derived from karyotypically unstable
cells be tested independently.
Finally, embryonal carcinoma cells are interesting in their own
right.

They differ from most other cells not only in that they are

pluripotent, but in their peculiar surface antigens, their resistance
to many viruses, and in the ability of some ECCs to produce either
tumors or normal mice depending on environment.

ECC hybrid cells

ought to give us a chance to test whether any of these properties
can be dissociated from the others with which it is usually linked.
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CHAPTER TWO:

PART 2A:

EXPERIMENTAL PROCEDURES

Materials

Unless otherwise stated, all biochemicals used were purchased
from Sigma Biochemical Co. (St. Louis, Mb.); tissue culture media
from Grand Island Biological Co. (Grand Island, N.Y.); serum for
tissue culture from either Grand Island, Flow Laboratories (Rockville,
Md.), or Microbiological Associates (Bethesda, Md.); radioactive
chemicals from New England Nuclear (Boston, Ma.); materials for
electron microscopy from Polysciences (Warrington, Pa.); and plastic
flasks and dishes for tissue culture from either Falcon (division of
B.-D. Laboratories, Los Angeles, Ca.) or Corning (Corning, N.Y.).

PART 2B:

Cell culture

Unless otherwise indicated, cells were grown in Dulbecco-Vogt
modified Eagle's medium, "high glucose" formulation, which was purchased
as a powder and made up in triply glass-distilled water, then filtered
through Millipore (Bedford, Ma.) filters with final pore size .22 vm,
and then supplemented with penicillin, streptomycin and kanamycin
(final concentrations of 50 U/ml, 50 pg/ml, and 100 pg/ml, respectively)
and 10% fetal calf serum.

This medium will be referred to as DVME-FC,

and serum-free medium as DVME-o.

Hybrid cells were selected and grown

in DVME-FC-HAT, produced by adding hypoxanthine, aminopterin
(Nutritional Biochemicals, Cleveland, Ohio), and thymidine (final con
centrations 13 mg/L, 0.19 mg/L, and 3.9 mg/L, respectively), prepared
47
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as a 10Ox concentrate, to DVME-FC.

Hepes buffer (20 mM, pH 7.6-7.8)

was sometimes added to media in which the hybrid cells were grown.
Embryonal carcinoma cell lines, as well as PCT and PCF hybrid
lines, were routinely fed on the second day after subculture, and
split again at a ratio of 1:10 or 1:20 on the third day, using Viokase
enzyme mixture (Grand Island) in a calcium- and magnesium-free balanced
salt solution which contained 1 mM Na^EDTA.
less frequent subculture.

Other cell lines required

All cells were grown at 37° in a humidified

atmosphere of 10% CO^ in air.

PART 2C:

Production of hybrid cells

PCT hybrids.

A suspension of thymocytes was prepared by teasing the cells from
freshly-dissected thymus glands of two four-week old C3H/HeJ female
mice into DVME-FC.

These cells were washed and then resuspended in

7
DVME-o at 2 x 10 /ml and chilled to 4 . Logarithmically-growing
PCC4azal cells were harvested with Viokase solution, washed once in
DVME-FC and once in DVME-o, and resuspended at 10^/ml.

The fusion

mixture contained 0.5 ml of each cell suspension and 1 ml of Dulbecco's
phosphate-buffered saline containing 1% bovine serum albumin and 500
hemagglutinating units of (3-propionolactone-inactivated Sendai virus
prepared by the method of Giles and Ruddle (1973) .

This mixture was

kept on ice for 20 min. and then swirled at 37° for another 65 min.
The cells were then washed once in DVME-FC and seeded into Falcon 25
2
cm flasks in DVME-FC-HAT.
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PCC4azal cells are very sensitive to HAT, and did not survive
the fourth day of incubation; nearly all thymocytes had died by then
as well.

By the ninth day of incubation, each of three flasks was

found to contain a single healthy colony of attached cells.

These

flasks were fed on day 9, and the medium which was removed from the
flasks at this (and several later) feedings cultured at 37° in the
hope of recovering live non-attached cells.

No growth was ever seen

in the cultured fluids, but two of the three attached colonies gave
rise to proliferating cell lines, which were named PCTA1 and PCTA2.
A second independent fusion was carried out in the same way,
except that a) only 2.5 x 10^ PCC4azal cells were used; b) the
thymocyte donor was a 6-week old C3H/HeJ female; and c) the incubation
at 37° was stopped after only 30 min.
were derived in this experiment:

Two clones of attached cells

PCTBla and PCTBlb.

Both lines were

derived from the same flask, and may have evolved from the same
fusion product.

A third colony was lost because of poor growth, and

no non-attached cells could be recovered from the culture fluids
retained from the early feedings.

PCF hybrids.

Five clones of PCF hybrid cells were produced in two separate
fusion experiments between PCC4azal and the BrdU-resistant, DMSOinducible Friend erythroblastic leukemia line, FBU.

In the first of

these, 4 x 10^ PCC4azal cells were mixed with 8 x iC^ FBU cells.

The

FBU cells, since their original isolation, had been grown in medium
containing 30 pg/ml BrdU to select against revertants, and had been
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grown in medium containing 2% DMSO for three days prior to the fusion
experiment.

1 ml of Sendai virus (500 HAU in Dulbecco's PBS with 1Z

bovine serum albumin) was added to the 1 ml of DVME-o in which the
mixture of cells had been resuspended.
4°

This mixture was then kept at

for 10 min, and incubated at 37° for another 20 min.

The cells

2
were then seeded into ten 25 cm flasks, and HAT additives were added
on the following day.

Of the several colonies of attached cells which

appeared within the next two weeks only one, PCFA8, survived for
further characterization.
A second experiment was carried out in a similar way, except that
the FBU culture had not been treated with DMSO prior to fusion.

Four

attached colonies of cells, all derived from separate flasks and hence
presumed to have originated in different fusion events, were isolated
for characterization:

PCFB1, PCFB2, PCFB3, and PCFB5.

Several flasks in these experiments were found to contain
proliferating populations of non-attached cells.

Clones obtained by

seeding these cells at a concentration of 1 cell/well in Falcon
microtest plates were found (by isozyme analysis) to be Friend cell
revertants.

It is possible that the non-attached populations

originally contained hybrid cells which were overgrown by FBD revertants
and therefore not recovered in the cloning experiments.

PART 2D:

Starch gels and chromosome analysis

Starch gel electrophoretic analysis.

Sonicates prepared from cultured cells and from homogenized mouse
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tissues were analyzed for isozyme content essentially by the methods
of Nichols and Ruddle (1973), except that harvested cells were
sonicated during the course of sample preparation.

Chromosome analysis.

Rapidly dividing cultures of hybrid and parental cell lines were
treated with Colemid (Ciba) at concentrations of 0.03-0.06 yg/ml for
1-4 hours, harvested, swollen in 0.075 M KC1 or in fetal calf serum
diluted with 3-5 volumes of distilled water, fixed in 3:1 methanol:
acetic acid, and air-dried onto clean slides.

These preparations were

stained with Giemsa or the fluorochrome 33258 Hoechst, unbroken and
well-spread metaphase preparations photographed, and chromosome counts
made either from the prints or from projected negatives.
PCC4azal cells contain two bi-armed chromosomes, of which one
(marker "P-l") is longer than any of the four bi-armed chromosomes found
in FBU cells.

FBU metaphases, on the other hand, contain two (probably

homologous) subaetacentrics (F-2) and two (probably non-homologous)
metacentrics (F-l) which can be distinguished from the remaining
PCC4azal metacentric (P-2) by staining with 33258 Hoechst.

Most mouse

centromeres fluoresce brightly after Hoechst staining, but the centro
mere of marker P-2 is much less bright than either of the Friend F-l
markers.

No attempt was made to identify specific chromosomes by

banding techniques.

PART 2E:

Electron microscopy

Monolayers of hybrid cells growing logarithmically in plastic
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tissue culture dishes were prepared for electron microscopy by the
method of Brinkley and Chang (1973).

Glutaraldehyde-fixed, osmium

post-fixed monolayers were dehydrated and embedded in Epon, sectioned,
stained with uranyl acetate and lead citrate, and then examined and
photographed with a Phillips 300 microscope.

PART 2F:

Measurement of alkaline phosphatase activity

Alkaline phosphatase activity (E.C. 3.1.3.1; APase) was measured
in cell sonicates by spectrophotometric quantitation of the hydrolysis
of p-nitrophenyl phosphate during a 15 min incubation at 37° and
pH 10.0.

The assay is essentially the same as that used by Bernstine

et al. (1973), and the results are expressed in the same units
employed by these workers.

To confirm that my results could be

compared directly with the values published by Bernstine's group, I
measured APase in mouse kidney sonicates.

As shown below (see Table

3-3), the average specific activity I obtained for this tissue (31.5
limol/hr/mg protein; s.e.m. 3.4) is similar to that obtained by
Bernstine (28.0; range 21.8-38.0).

I assayed each sonicate in

duplicate on the day of preparation, and the duplicate values were
averaged to obtain a specific activity for that day's enzyme prepara
tion.

The means shown in Tables 3-3 and 3-4 are thus averages of

different daily preparations.

PART 2G:

Infection of cultured cells by Minute Virus of Mice

The Crawford strain (Crawford, 1966) of the parvovirus MVM
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("Minute Virus of Mice") was obtained from Dr. D. Ward as a suspension
at 5 x 107 plaque-forming units (PFU) /ml in DVME with 5Z fetal calf
serum, together with a fluorescein-conjugated rabbit antiserum to MVM
virions.

Details of virus preparation and titration, and antiserum

production and conjugation are given in Miller, Ward, and Ruddle
(1976; submitted for publication.)
Cells which were to be tested for the ability to support MVM
infection were seeded in counted numbers onto Lab-Tek 8-chamber slides
(Miles Laboratories) at 1-3 x 10

4

2
cells/1 cm chamber.

After an over

night incubation to permit the cells to attach, each monolayer was
washed once in DVME-o.

Virus was added in 0.2 ml of DVME-o, at a

multiplicity of 20 PFU/plated cell.

(Assuming one population doubling

between subculture and virus addition, this gives an effective
multiplicity of infection (MDI) of 10.)

The virus was removed 1 hr

later, the appropriate serum-containing medium added (0.3 ml/chamber),
and incubation continued at 37° for 15-20 hr.
Virus-treated cell cultures were then tested for the presence of
MVM antigens by an indirect immunofluorescence assay.

Slides to be

tested were washed briefly in PBS at room temperature, fixed in 3:1
methanol:acetone for 10 min at room temperature, and air-dried.

A drop

of anti-MVM serum, diluted 1:40 with PBS, was placed on the slide and
covered with a coverslip to distribute the serum evenly over al 1 eight
chambers.

After 30 min at 37°, the slide was washed in three changes

of PBS, shaken to remove most of the PBS, and covered in the same way
with a fluorescein-conjugated IgG fraction of goat antibody to rabbit
IgG (Microbiological Associates), diluted 1:20 in PBS.

After a second

30 min incubation, the slides were washed in three changes of PBS,
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counterstained with 0.005% Evans Blue in PBS with 1% FCS for 30-60
sec, and rinsed in water.

Fluorescent preparations were examined

and photographed with a Leitz Orthoplan microscope using mercury
illumination deflected through a Ploemopak vertical fluorescence
illuminator carrying a filter system designed to provide wide-band
blue illumination (Leitz Filter System H, which includes two KP490
excitation filters, a TK510 dichroic prism, and a K510 barrier filter).
Cells which grew in suspension (FBU and concanavalin-stimulated
mouse splenic lymphoid cells) were infected at an MOI of 10 and a
cell concentration of 2 x 10^/ml in DVME-FC (FBU) or 10^/ml in RPMI-FC
(lymphoid cells).

After 18-19 hr, the cells were washed in DVME-o,

resuspended, and a drop of suspension placed on a microscope slide and
air-dried.

These slides were then fixed and stained as described

above.

PART 2H:

Production of tumors from hybrid cells

Cells were harvested in 0.02% Na^EDTA in PBS, washed in DVME-o,
and injected in counted numbers subcutaneously into young adult mice.
Some of the tumors were grown in homozygous nu/nu mice (partially
inbred onto a Balb/c background; Freedman and Shin, 1974), which are
genetically deficient in their cell-mediated immune response.
tumors were grown in syngeneic animals:

Other

PCT cells in (C3H/HeJ x

129/Sv)F^, and PCF in (DBA/2J x 129/Sv)F^ mice.

The nude mice were

raised and inoculated by Dr. S. Shin at Albert Einstein College of
Medicine, and the syngeneic animals bred and inoculated here at Yale.
Both kinds of host animals produced similar sorts of tumors.

After
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17-45 days, animals with tumors were killed by cervical dislocation,
and their tumors removed, fixed in aqueous Bouin’s fluid, embedded in
paraffin, sectioned at 4-5 pm, stained with hematoxylin and eosin, and
examined with a Leitz Orthoplan microscope.
To learn whether tumor formation had been accompanied by changes
in chromosome complement, I prepared cultures from 4 of the PCT tumors
at autopsy, from which chromosome preparations were made 3-4 subculturings after derivation.

PART 21:

a-fetoprotein (AFP) production by hybrid tumors

Blood was drawn from some of the tumor-bearing animals just prior
to sacrifice.

Serum from these mice was tested, after storage at -50°,

for the presence of mouse AFP by the discontinuous counterimmunoelectrophoretic technique of Wallis and Melnick (1971, 1972).

Micro

scope slides were coated with 1% agarose (Seakem) gel containing 12 mM
barbital buffer (pH 8.6), and wells punched into the agarose were
loaded with about 5 yl of the antigen to be tested, diluted 1:4 with
buffer.

Rabbit antiserum to mouse AFP was pipetted into the cathodal

series of wells.

Slides were then subjected to electrophoresis at 200

volts/8 cm slide, for 30 min at room temperature.

Reservoir and bridge

buffers were at five-fold higher buffer concentration.

The antiserum

used (the gift of Dr. B. Ledford) was produced in a rabbit injected
with electrophoretically purified AFP isolated from a cultured mouse
hepatoma line, Hepa.
to use.

The serum was absorbed with mouse albumin prior

I have tested the specificity of this serum in several ways.

First, it gives a single precipitin line in a standard immunoelectro-
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phoretic assay when tested against either mouse amniotic fluid, Hepa
culture fluid, or serum from a mouse carrying an OTT6050 ascitic
teratocarcinoma; the antiserum, however, produced no precipitin line
when tested against adult mouse serum.

Second, when this antiserum is

compared with a second, independent anti-AFP serum, produced by Dr. E.
Zimmerman by immunization of a goat with mouse amniotic fluid-derived
AFP, a line of identity is produced in double diffusion analysis,
using mouse amniotic fluid as antigen.

I used the rabbit antiserum

to mouse AFP at a dilution of 1:4 in 12 mM barbital buffer.
After discontinuous counterimmunoelectrophoresis, the agarosecovered slides were washed for 2-4 days in several changes of saline,
washed once overnight in distilled water, dried, stained with 0.025%
Coomassie Blue B in a mixture of methanol, water, and acetic acid
(45:45:10), and destained in the same solvent mixture.

PART 2J:

Production and titration of anti-Thy-l alloantiserum

An alloantiserum to detect the presence of Thy-1.2 antigen was
prepared by a method based on that of Reif and Allen (1964a) .

Strains

v
AKR/J and C3H/HeJ are both H-2 , but differ at the Thy-1 locus, so
that immunization between these strains produces a serum uncontaminated
by anti-H-2 antibody.

Such sera may, however, contain antibodies

directed against molecules unrelated to Thy-1 antigen.
AKR/J female mice (7 weeks old when first inoculated) were injected
intraperitoneally, once a week, with a suspension of C3H/HeJ female
thymocytes, at a concentration of 10^ cells/0.2 ml inoculum.

The

recipient mice were bled from the tail 6 and 10 days after the fifth
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Injection. Antiserum was heat-inactivated (to remove complement) at
54® for 30 min, and stored in aliquots below -50°.
This antiserum was titred in a one-step cytotoxic test against
C3H/HeJ thymus target cells.

Equal volumes of diluted antiserum,

diluted rabbit serum (as complement source) , and cells (2 x 10^/ml)
were mixed and incubated at 37° for 45 min, after which trypan blue
was used to assess cell death.

The serum, in the presence of comple

ment, killed more than 95Z of the target cells at high concentrations,
and killed 53Z at a dilution of 1:1280.

DVME-o with 4% heat-inactivated

fetal calf serum was used as diluent.
nhcu titred in the two-step cytotoxic test employed (see below)
for absorption analyses on ECC and hybrid cells, this serum killed more
than 50% of the target C3H thymocytes at a dilution of 1:2000.

PART 2K:

Cytotoxic absorption tests for cell surface antigens

Hybrid cells and appropriate controls were tested for the presence
of H-2 and Thy-1 cell surface antigens by a modification of a standard
method (e.g. Artzt and Jacob, 1974) involving absorption of cytotoxic
antibody from well-defined sera.

In the usual test, the antiserum is

first titred for cytotoxic activity against target lymphoid cells by
mixing counted numbers of target cells with a series of dilutions of
the antiserum.

After a period of sensitization, during which antibody

binds to the cells, complement (Cf) is added.

After a further 45 min

incubation at 37°, the fraction of the target cell population still
viable is measured, e.g. by counting the proportion still able to ex
clude a dye, trypan blue, which only enters dead cells.
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After this titration, cells of interest can be tested for antigen
by an absorption assay, as follows.

A fresh aliquot of the antiserum

is diluted to the lowest concentration found to kill 60-90% of the
target cells.

The diluted serum is then mixed with the cells in whose

surface antigens one is interested.

After an incubation, the cells are

spun out, and the absorbed serum tested for residual cytotoxicity
against target cells.

What one learns from the absorption test is

whether the tested cells carry antigens which cross-react with those
both a) present on the target cell, and b) recognized by the antiserum
used.
In a series of preliminary experiments not to be discussed here in
detail, I observed that when this standard cytotoxic test was used,
embryonal carcinoma cells and their hybrids often seemed to absorb
cytotoxic antibody even from sera from which no absorption ought to
have been observed.
H-2

F9 cells, for example, absorbed cytotoxic anti-

antibody, even though they did not carry the specificities detected

by the serum used.

Several attempts to circumvent this non-specific

absorption— e.g., by pretreating the F9 cells with bovine serum
albumin, or pre-absorbing the anti-H-2 serum with F9 before use— all
failed to prevent absorption, by F9 cells, of cytotoxic activity in
excess of the small amount absorbed by negative control cells.

In

addition, I found that F9-absorbed sera were often more cytotoxic if
diluted 1:2 than if used without dilution.
This last observation suggested that absorption of sera with ECCs
might be rendering the sera anti-complementary.

Were this the case,

one would expect that F9-absorbed sera would always be less cytotoxic
than control—absorbed aliquots, not because the F9 cells had removed
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antibody, but rather because F9-absorbed serum, when mixed with C', in
some way inhibited the C '-dependent cytotoxic reactions.

The increase

in cytotoxic activity after a 1:2 dilution could be due to such an
inhibitory influence if it acted with different stoichiometry than
did antibody.

Interference from anti-complementary activity could be

overcome by modifying the cytotoxic test to prevent contact between C'
and the absorbed serum.

When such a modified test was carried out

(see below), I began to obtain consistent results with acceptably low
absorption in cases where ECCs were used as negative controls.
The cytotoxic test used to produce the results reported below was
therefore carried out as follows:
1.

Cells to be tested for surface antigen content were freed

from monolayer cultures by two washes in PBS, followed by a 5 min
incubation in PBS with 0.02Z Na^EDTA.

Cells were shaken free, poured

into an equal volume of cold diluent (DVME with 4% heat-inactivated
fetal calf serum), sedimented at 4° (800 rpm, 4 min in an IEC model
PR-6 with a #253 head), and resuspended in diluent.

The cells were

then packed by centrifugation at 1500 rpm for 5 min.
Lymphoid cells to be tested were teased from the appropriate
organs into diluent, washed twice, and pelleted at 1500 rpm for 5 min.
Cultured suspension cells were prepared in the same way as
lymphoid cells, except that they were washed three times.

In an experi

ment not shown, PBS-EDTA treatment of suspension cells was shown not
to diminish detectably their ability to absorb anti-H-2 antibody.
2.

Absorption.

An appropriate alloantiserum (see below) was

diluted to a level just sufficient to kill 60-90Z of target cells, and
stored frozen in aliquots containing enough serum for one day's use.
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50 pi of diluted serum were pipetted into each of a set of 400 pi
tubes.

The pellet of cells prepared in step #1 above was carefully

freed of surface diluent, and 25 pi of packed cells were transferred
to the tubes of serum.

The cells were dispersed in the serum by

gentle agitation, and the tubes incubated at 4° for 40 min, after
which the cells were pelleted in a Beckman micro fuge.
3.

Target cells were prepared by teasing the mesenteric lymph

node (for H-2 assays) or thymus gland (for Thy-1 assays) into diluent.
Cells were triturated, washed three times in the cold, counted, and
suspended at 2 x 10^/ml.
4.

20 pi each of diluent, absorbed antiserum, and target cell

suspension were pipetted into 3 ml conical tubes kept at 4°.

Each

absorbed serum sample was divided into two 20 pi portions and thus
assayed in duplicate.

Each series of tubes included two in which

diluent was substituted for antiserum ("C1 only control") and two in
which unabsorbed serum was used.

Each batch of diluted antiserum was

tested to verify that cell death in its presence was in fact C'dependent, but this control was not repeated for each day's work.
These tubes were incubated for 40 min in an ice-water bath.
5.

After this sensitization, target cells were washed in 2.5 ml

of diluent and sedimented (10 min, 800 rpm, 4°).

Supernatant was

removed except for an estimated 25 pi covering the pellet.

50 pi of

rabbit C', absorbed with A9 cells as described below, and diluted to
a concentration found to be optimal for each batch (ranging from 1:8
to 1:12), was then added.

The cells were resuspended, warmed quickly

to 37°, and incubated for 45 min at this temperature.
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6.

The tubes were then placed in an ice-water bath, and 50 yl

of .20Z trypan blue in saline was added before an aliquot was examined
in a heaocytoaeter.

(The trypan blue was stored as a .25Z solution in

water, and mixed with .25 vols of 4.2Z NaCl just before use.)

1QQ

cells were counted from each tube.

Calculations.

The fraction of cells killed by a particular aliquot of absorbed
serum is not itself the most

useful measure of the ability of the

absorbing cells to remove antibody, since this value is subject to
several influences which suffer day-to-day variations: e.g. the initial
viability of the target cell population, susceptibility of a given
mouse's cells to C', minor diluting errors, incubator temperature,
etc.

For this reason, the counted fraction of viable cells was con

verted into a measure of "residual cytotoxicity" as follows:
1.

Cytotoxic index (Cl) was calculated as
T - C
100 - C

where T is thefraction
C is the fraction

killed in the serum being tested and
killed in the C'-only control.

This figure expresses killing as a fraction of the live cells not
killed by C' alone, and compensates for variations in C' activity,
initial cell viability, and susceptibility to C 1.

The Cl for the C'-

only control is by definition zero.
2.

Residual cytotoxicity (RC) is calculated for each absorbed
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serum as

100 x Cl (T)

Cl (U)
where Cl (T) is the cytotoxic index for the absorbed serum being
tested and Cl (D) is the cytotoxic index for the unabsorbed control.
The RC for the unabsorbed control is thus by definition 100.

Complement.

Complement (C’) for use in cytotoxic tests was prepared by the
method of Boyse e£ al. (1970).

Rabbit serum (either drawn from

selected rabbits by cardiac puncture or purchased frozen from Grand
Island Biological Co.) was made 10 mM in Na^EDTA by addition from a
lOx stock.

The serum was then absorbed with A9 cells (washed several

times in DVME-o) at 4° for 30 min with occasional agitation.

Different

batches of C' were absorbed with packed volumes of A9 cells ranging
from 10-25Z of the C' volume.

During the absorption, naturally-

occurring rabbit antibody to mouse cell surface antigens is removed,
while the EDTA prevents consumption of C'.

After the absorption, the

C' was separated by centrifugation at 4° for 5 min at 2000 g, and
enough 20 mM C a C ^ added to compensate for the EDTA.

Absorbed C' was

stored in 0.5 ml aliquots at -90°; once thawed, an aliquot was never
refrozen for later use.

Specificity.

It is important to recognize the limitations of specificity in this
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technique as used with currently available antisera, and the tricks
which are used to improve specificity.

If, for example, one produces

an "anti-H-2^" serum by injecting A9 cells (C3H/HeJ; H-2^) into Balb/c
mice (H-2^), and then uses this serum to kill A9 cells in a cytotoxic
test, one will be able to detect H-2
cells used for absorption.

antigens on the surfaces of

Such a system is, however, not specific

for H-2 antigens, since the serum may well contain antibodies to other
surface molecules (viral antigens, minor H antigens, etc.) present
both on the immunizing and target cells.

The principal precaution

used to increase the specificity of cytotoxic tests is to use coisogenic mice throughout.

To test for H-2 , for example, one might

produce an antiserum in C57BL/10 ("BIO") mice by injection of lymphoid
cells from the co-isogenic strain B10.BR, which differs genetically
from its parental strain BIO only by the introduction of genes closely
linked to the H-2

complex introduced from the C57BR strain.

Such an

antiserum, if tested on B10.BR target cells, will only detect surface
antigens coded for, or controlled by, genes closely linked to the
major histocompatibility complex (MHC) and the H-2 loci.
It is worth noting that such a test system is still not entirely
specific for any single antigen.

Among the complicating factors are

the following:
1.

H-2 haplotypes contain two loci, called K and D, which produce

highly immunogenic cell surface antigens.

An antiserum can often be

made specific for one or the other of these loci by the use of appro
priate strains, one of which has undergone intra-MHC recombination.
Both of the H-2 antisera used in this study (see Table 2-1) are of this
type, and are directed against H-2K molecules.
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TABLE 2-1
SYSTEMS FOR CYTOTOXIC TESTS OF H-2 ANTIGEN EXPRESSION

Antigen

Serum

Immunogen

Responder

Target

H-2 Specificities Detected

H-2

D33

BIO.A (5R)

(B10.D2 x A)F

C57BL/10

33, 53, 54

KbDd

KdDd x K V

KbDb

C3H

(C3H-H-2

B10.BR

kV

KdDk x KbcDbc

H-2

D3b

x 129)Fx

(H-2K )

11, 23, 25, 52 (H-2K )

KkDk

Details of the immunization procedures are given in Snell (1968).

These sera were obtained

through Dr. John Ray of the Collaborative Research office of the National Institute
of Allergy and Infectious Disease, NIH.

The underlining indicates the molecule that

the antiserum was designed to detect; as noted in the text, these antisera may contain
antibodies directed against other molecules as well.

65
2.

Cross-reactions, due to the so-called "public specificities",

may occur between different individual H-2 antigens.

Reference to a

list of H-2 specificities (Klein, 1975, p. 126) can help one to decide
whether a particular antiserus-target cell combination can detect a
public specificity likely to be present on the cell whose surface
composition one wishes to examine.
3.

Recent work has shown that the MHC includes genes which code

for surface molecules other than H-2K and H-2D; these new antigens are
called la antigens (for review, see Klein, 1975, pp. 450-54.
recent information on strain distributions, see G&'tze, 1976.)

For
In

addition, it is likely that the MHC contains loci coding for surface
antigens still to be recognized.

Anti-H-2 sera, even those produced

through immunization of co-isogenic strains, may be "contaminated"
with antibodies to the products of these loci.

It is also possible

that some of the MHC gene products act to control the expression of
surface antigens coded for in other areas of the genome.
Table 2-1 summarizes the cytotoxic systems used in this dissertab
k
tion to test for H-2K and H-2K antigens.

For the reasons just stated,

a cautious interpretation of results obtained using such sera would be
that although most of the absorption of cytotoxic activity brought
about by a test cell is likely to represent classical H-2K determinants
on the cell surface, one cannot rule out absorption due to the products
of loci which are linked to H-2 but are not yet well-defined.

PART 2L:

Measurement of acetylcholinesterase activity

Acetylcholinesterase (E.C. 3.1.1.7; AChE), an enzyme present at
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high specific activity in erythrocytes, is also found in Friend erythroleukemia cells (Conscience et al., submitted for publication), but not
in embryonal carcinoma cells (see below).

PCF hybrid clones were

tested for AChE activity essentially by the method of Lewis and
Eldefrawi (1974).

Harvested cells were sonicated in 50 niM phosphate

buffer, (pH 7.4, 1Z in NP40 detergent); the sonicate was clarified by
centrifugation (30,000 g, 30 min, 4°) and divided into aliquots which
were frozen until use.

The reaction was carried out in a total volume

of 150 pi, and is based on the measurement of radioactive acetate re
leased from acetylcholine substrate during a 20 min incubation at room
temperature.

Acetate is separated from unhydrolyzed substrate by thin

layer chromatography on strips cut from Gelman Type SA ITLC plates,
using 80Z ethanol as solvent, which are tested for radioactivity.

Each

set of assays included duplicate determinations for each aliquot, as
well as blanks in which 1Z NP40 in buffer was substituted for the
enzyme solution.

The percent hydrolysis given by the blank was sub

tracted from each result before further calculation; this correction
averaged 6-8Z hydrolysis, and was in most cases roughly 10-fold greater
than the hydrolysis attributable to enzyme activity in ECC and PCF
sonicates (blank-corrected), though of course much lower than the
hydrolysis produced by FBU sonicates.

PART 2M:

Other methods

Friend cells and cells harvested from monolayer culture were
stained for hemoglobin by the benzidine method of Orkin et al. (1975).
Two drops of benzidine solution were added to a single drop of cell
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suspension in a well of a Falcon micro test plate.
Protein was measured by the method of Lowry et al. (1951), using
bovine serum albumin as a standard, during the course of enzyme assays.
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CHAPTER THREE:

PART 3A:

RESULTS

Demonstration that PCT and PCF cells are in fact hybrids

PCT cells.

As described in Part 2C, above, two monolayer cell lines, PCTA1
and PCTA2, were derived from a Sendai-mediated fusion between PCC4azal
and C3H/HeJ mouse thymus cells.

A second, similar fusion produced two

other cell lines, PCTBla and PCTBlb, which appeared as separate colonies
in the same flask, and might therefore have been derived from a single
fusion product.

Attempts to isolate lines of non-attached cells from

the fusion mixtures were unsuccessful.
Because these cell lines grew in a medium (DVME-FC-HAT) in which
neither parent was able to divide, they were presumed to be hybrids.
Two experiments were carried out to test this presumption.
Sonicates of each of the four cell lines, together with appropriate
controls, were checked by starch gel electrophoresis for their pattern
of glucose phosphate isomerase (GPI; E.C. 3.5.1.9) isozymes.

Figure

3-1 shows that each of the four cell lines contains both the GPI-A
marker characteristic of the PCC4azal parent and the GPI-B enzyme found
in the C3H/HeJ thymocyte parent, as well as an AB heterodimer found
only in cells carrying alleles for both forms.

A cell containing equal

numbers of active A and B alleles would be expected to produce the three
isozymes in ratios of 1:2:1 (AA:AB:BB); the relative densities of the
three bands in the PCT cell lines, as in the (C3H/HeJ x 129/J)F^ hybrid
mouse thymus control, conform moderately well to this expectation.
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Figure 3-1

Glucose phosphate isomerase isozymes in PCT hybrids and controls.
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result shows that each PCT line contains cells with some genetic input
from each parental cell, and suggests that each hybrid line arose from
the fusion of one thymocyte with one ECC.
Chromosome analysis supported this idea.

Figure 3-2a shows a

metaphase preparation of a typical PCT hybrid cell, and figure 3-3
presents histograms of chromosome number for each of the PCT lines.
Table 3-1 shows the summary statistics derived from the chromosome
counts of these lines and of the PCC4azal parent.

The expected

values shown in this table are based on the assumptions that the
thymus parent contained 40 acrocentric chromosomes, that the PCC4azal
parent contained the modal number of its population (39) including both
of the bi-armed marker chromosomes, and that no chromosome loss occurred
after fusion from a 1:1 hybrid.

The PCT hybrid populations contained

92-95% (means) of the expected chromosome number, and 80-90% of the
hybrid metaphases showed both of the PCC4azal marker chromosomes.
Although it is conceivable that extensive chromosome loss has taken
place, accompanied by reduplication of the remaining chromosomes, it
seems far more likely that each hybrid cell contains most of the
chromosomes introduced by each parent.
The chromosome analysis, together with the GPI isozyme pattern,
shows that these cell lines are products of fusions between single
thymus cells and single PCC4azal cells.

Each parent probably contributed

about the same amount of genetic material to the initial hybrid cell.
The results of serological analyses to be presented below show
that the PCT lines also contain a second marker from the thymus parent,
H-2^, and that at least three of the lines carry the H-2tc allele found
in the 129/Sv parent from which PCC4azal was derived.

Jfewaa*Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 3-2

Metaphase preparations of hybrid cells and parents.
a)

PCTA1.

Giemsa-stained.

b)

PCC4azal.

c)

FBU.

Hoechst-stained.

d)

PCFB2

(passage 8).

71 acrocentrics; 1 P-l; 1 P-2.

Hoechst-stained.

37 acrocentrics; 1 P-l; 1 P-2.

34 acrocentrics; 2 F-l; 2 F-2.

Hoechst-stained.

96 acrocentrics;

1 P-l;

2 P-2; 2 F-l; 2 F-2.

Code:

P-l

single triangle,

P-2

double triangles,

F-l

single arrow,

F-2

double arrows.

Note that photographs shown are not to the same scale.

Note the presence

of two doses of PCC4azal marker P-2 in the PCFB2 metaphase shown.
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Figure 3-3

Distribution of chromosome numbers in PCT hybrid populations.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

w 10
<D
si 8
E
3
Z 6
4
"3
o 2

PCTA1

10

20

30

40

_L

_i_L

50

60

70

80

90

Number of Chromosomes

w

0>

10

PCTA2

8
i 6

1

i
o

4
2
I

10

20

I______I______I______L

30

40

50

60

. i H
70

J_____ L

80

90

136

Number of Chromosomes

a?

10

Si 8
E
3
Z

PCTBIa

6

=

a> 4
O 2
10

20

30

_L

_L

_L

40

50

60

A

70

80

90

Number of Chromosomes

w 10
8
E
3 6
z
4
"53
o 2

<V
Si

PCTBIb

_L

10

20

30

40

. 1^
50
60
70
80
Number of Chromosomes

90

149

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TABLE 3 -1

CHROMOSOME CONSTITUTION OF PCT HYBRID CELLS

Mean #

S.D.

N

PCTA1

75

2.8

39

97

PCTA2

73

3.7

20

85

PCTBla

75

3.2

21

86

PCTBlb

74

3.3

23

87

PCC4azal

38

1.7

32

100

Cell Line

Thymocytes
Expected

% With 2 Bi-armed

(40)

(0 )

79

100

Values given are the mean numbers of chromosomes found in N
metaphases examined for each cell line, except that the values given
for thymocytes were assumed.
distribution.

S.D. gives the standard deviation of the

Expected values (for a 1:1 hybrid) are based on the

assumptions given in the text.

Values for mean and S.D. for PCC4azal

were computed after excluding near-tetraploid cells which are, however,
included in the histogram (figure 3-6).

Note that the strong modal

value for the PCC4azal population, 39, is slightly above the mean
chromosome number.
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PCF cells.

As described in Part 2C above, five monolayer cell lines were
derived from two fusion experiments between PCC4azal and the Friend
ppII line FBU.

A single clone, PCFA8 , survived the first experiment;

the second produced four independent clones:
PCFB5.

PCFB1, PCFB2, PCFB3, and

Attempts to isolate lines of non-attached hybrid cells were

not successful.

The PCF cells grew well in DVME-FC-HAT, and were

tested further to see if they were truly hybrid.
The mouse strains, 129/Sv and DBA/2J, from which PCC4azal and FBU
were, respectively, derived differ genetically with respect to the
isozymes phosphoglucomutase (PGM:
genase (IDH; E.C. 1.1.1.42).

E.C. 2.7.5.1) and isocitrate dehydro

Each putative PCF hybrid clone was tested

for PGM and IDH isozymes within 6-10 passages of its original isolation.
Figure 3-4 shows that each of the PCF clones (together with a clone,
PCFB4, which was subsequently lost) has both the two bands of PGM-1A
activity characteristic of 129/Sv (PCC4azal) cells, and the two bands
of PGK-1E activity of the DBA/2J (FBU) parent.
similar results for IDH.

Figure 3-5 shows

PCC4azal has a slower-migrating isozyme,

IDH-1A, while the faster IDH-1B form is characteristic of FBU cells.
Each hybrid clone has both these isozymes, together with an AB heterodimer.

It is worth noting that the A and B forms seem to be of equal

intensity in PCFB3 and PCFB5 sonicates, but that sonicates of PCFA8 ,
PCFB1, and PCFB2 have more of the PCC4azal form, and more dimer, than
they have B isozyme.

This suggestion of a greater ECC contribution to

the latter three hybrid clones is confirmed by the chromosome data
to be discussed next.
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Figure 3-4

Phosphoglucomutase isozymes in PCF hybrids and controls.
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Figure 3-5

Isocitrate dehydrogenase isozymes in PCF hybrids and controls.
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Figure 3-6 shows the distributions of chromosome numbers in meta
phase spreads prepared from these cell lines.

The results shown by

open bars (for PCFA8 and PCFB2) were obtained 21-26 passages after the
data indicated by the closed bars.

Table 3-2 gives summary statistics

condensed from the histograms and data on the presence, in the hybrid
cells, of marker chromosomes characteristic of the two parental popula
tions.

The "expected" values are based on the assumptions mentioned

above in connection with the PCT chromosome data, except that expected
values for 2:1 (PCC4azal:FBU) hybrids are also given.

Figure 3-2

(b,c,d) presents a Hoechst-stained metaphase spread of a typical PCF
hybrid cell, together with similar preparations from each parental line.
The IDH data illustrated in figure 3-5 and discussed above suggests
that PCFB3 and PCFB5 were each the product of fusion between equal
numbers (presumably one) of PCC4azal and FBU cells.

The chromosome

numbers are consistent with the idea that these clones originated in
1:1

fusions, followed by loss of about

complement.

10%

of the initial chromosome

On the basis of length, centromere position, and intensity

of centromere staining with the fluorochrome Hoechst 33258, it is
possible to distinguish from one another four kinds of bi-armed
chromosomes in PCC4azal and FBU cells.

Two of these (P-l and P-2) are

present in PCC4azal, and most of the PCFB3 and PCFB5 metaphases had a
single copy of each of these markers.

F-l and F-2, similarly, are FBU

markers, each represented in two examples in FBU cells.

(It is not

clear whether these represent two sets of similar but distinct chromo
somes.)

Most PCFB5 metaphases had two examples of each Friend cell

marker, and most PCFB3 cells had two examples of F-2 and one of F-l.
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Figure 3-6

Distribution of chromosome numbers and markers in PCF hybrids and
parental populations.
Note that two separate chromosome preparations were performed on
clones PCFA8 and PCFB2.

The distributions indicated by the

open bars were obtained 21-26 subculturings after those
indicated by the closed bars.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

20
18
16
14

PCC4aza1

12

10
8
6
4
2
0
14
FBU

12

10
8
6
4
2
0
4

PCFA8

2
0
6
4
2
0

,inn p in U M .
PCFB1

pi i , l l j t i

8
6
4
2
0

PCFB2

6
4
2
0

PCFB3

8
6
4
2
0
30

i

l

k

JUL

m

i

PCFB5

40

50

60

il
70

80

90

100

110

120

130

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

85

TABLE 3-2

CHROMOSOME CONSTITUTION OF PCF HYBRID CELLS

Cell Line

Mean #

S.D.

N

Markers (>30% of Cells)
P-l

P-2

F-l

F-2

PCC4azal

38

1.7

32

1

1

0

0

FBU

39

1.9

29

0

0

2

2

Expected (1:1)

78

-------

—

1

1

2

2

PCFB3

70

5.8

38

1

1

1

2

PCFB5

73

4.0

33

1

1,0

2

2

Expected (2:1) 117

-------

—

2

2

2

2

PCFA8

94

9.7

16

1,2

2

1,2

1,2

PCFB1

107

10.3

34

2

1

2,1

2,1

PCFB2

97

12.1

18

2,1

2

2,1

2

For each cell line, N cells were counted to give a mean total
chromosome number/cell, and a standard deviation (S.D.) was computed
from the distribution.

Four "marker" chromosomes could be distinguished

on the bases of length, centromere position, and affinity for Hoechst
33258 dye.

The numbers given for marker chromosomes are modal, and include

all modes in which at least 30% of the cells of a given population joined.
When two modes are given, the one listed first was the more common.
Assumptions used to compute expected values are as given in
the text.

Note particularly that the strong mode of the PCC4azal

population, 39, is slightly higher than the mean number of PCC4azal
chromosomes.
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The data are consistent with the idea that these hybrids resulted from
a

fusion.

1:1

Similar considerations support the hypothesis that PCFA8 , PCFB1,
and PCFB2 are the products of fusions between one Friend cell and two
PCC4azal cells, although chromosome loss seems to have been more exten
sive than in the 1:1 hybrids.

Note particularly the frequent presence,

in metaphases of these three lines, of two copies of the PCC4azal bi
armed markers.

The histograms for lines PCFA8 and PCFB2 shown in

figure 3-6 support the notion that these cells can lose chromosomes
during their period in culture.
In summary, and given the caveats discussed above with reference
to the PCT lines, the chromosome and isozyme analysis of the PCF clones
demonstrates that the cells are indeed hybrid, that PCFB3 and PCFB5
retain most of the chromosomes contributed by each genome, and that the
other three PCF clones, after formation from the fusion of two PCC4azal
cells with a single FBU cell, progressively lose up to 25% or more of
their original chromosome complement.

PART 3B:

Morphology of PCT and PCF cells in culture

PCT cells.

Figure 3-7a shows what PCT cells look like when grown logarithmical
ly as monolayer cultures on plastic substrates.
show,

Figures 3-7b and 3-7c

for comparison, the two parental cell types.

PCT cells, like

their ECC parent, grow as clusters of loosely attached cells.

The ratio

of nuclear volume to cytoplasmic volume is high compared to that of many
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Figure 3-7

Morphology of cultured PCT and parental cells.
a)

PCTBla.

Phase contrast; 330x.

b)

PCC4azal.

c)

Mouse thymocytes.

d)

PCTA1.

Phase contrast; 330x.
Phase contrast; 330x.

Transmission electron micrograph; 4900x.
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other cultured cell types.

By phase contrast, the nucleus typically

contains a single prominent phase-dense nucleolus within an otherwise
phase-lucent nucleoplasm; there is very little chromatin emargination.
Nuclei with two prominent nucleoli are more common in PCT cultures than
in the PCC4azal parental line, probably because the former cells are
near-tetraploid.

Although no one of these traits is diagnostic of ECCs,

together they make up a gestalt which is sufficiently compelling to have
induced experts in teratoma cultivation (F. Jacob, personal communica
tion) into mistaking cultured PCT cells for their PCC4azal parent.
The electron micrograph shown in figure 3-7d demonstrates that PCT
cells closely resemble PCC4azal cells at ultrastructural resolution as
well.

The numerous free ribosomes, paucity of endoplasmic reticulum,

lack of distinctive organellar apparatus, and predominance of euchromatin in the nucleus have all been described by other workers (see
Damjanov and Solter, 1975) as characteristic of ECCs.

Stobo et al.

(1972) present several electron micrographs of murine thymocytes.

Like

ECCs, thymocytes have a high nucleus/cytoplasm ratio, few cytoplasmic
organelles, and numerous free ribosomes.

Thymocyte nuclei, however,

unlike the nuclei of PCC4azal and PCT cells, contain large amounts of
condensed chromatin, distributed throughout the nucleus but especially
plentiful at the nuclear periphery.

Paulin et al. (1976) have found

biochemical correlates of the unusual nuclear morphology of ECCs; it
would be interesting to test the composition of the nuclear proteins of
PCT hybrid cells with this in mind.

Thymus cells, of course, also

differ from PCT and PCC4azal cells in that they do not form clumps and
do not attach to the surface of tissue culture flasks.
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PCF cells.

Figure 3-8 shows what cultured PCF cells look like, and shows, for
comparison, phase contrast micrographs of the two parental cell types.
Figure 3-8d is an electron micrograph of a section through a PCFB3
culture.

Although PCF cells usually have more than one nucleolus

(perhaps because they have more than one diploid equivalent of genome),
the morphological similarities to PCT hybrid cells and PCC4azal cells
are apparent.

Some of the PCF cells in the cluster shown in figure 3-8a

have formed a mound rising above the plastic surface into the medium;
this growth habit is typical of many ECC cell lines, though not of
PCC4azal itself.

The electron micrograph shows that the PCF cells

resemble ECCs at ultrastructural resolution as well.

(The section shown

happens not to have passed through a nucleolus.)
Sato et al. (1971) have discussed the ultrastructure of Friend
cells as part of their study of DMSO-induced changes in these lines.
They found that Friend cells, prior to any exposure to DMSO, and like
PCC4azal and PCF cells, have high ratios of nuclear volume to cytoplas
mic volume, and numerous free ribosomes.

Friend cell cytoplasm also

contains occasional lipid vacuoles and intracisternal A-type particles.
The most obvious ultrastructural difference between Friend cells, on
the one hand, and ECC and PCF cells on the other, is in nuclear morphol
ogy.

Friend cells have large amounts of emarginated heterochromatin,

and two nucleoli which, in stained preparations, are much less prominent
than the single ECC nucleolus.

Cultured Friend cells also neither clump

nor attach to plastic surfaces (although one can select for weaklyattached Friend cell populations.)
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Figure 3-8

Morphology of cultured PCF and parental cells.
a)

PCFB2.

Phase contrast; 330x.

b)

PCC4azal.

c)

FBU.

d)

PCFB3.

Phase contrast; 330x.

Phase contrast; 330x.
Transmission electron micrograph; 6000x.
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In view of the fact that other teratocarcinoma hybrids, including
hybrids with neuroblastoma cells (Evans, 1975), are said to have re
sembled fibroblasts, it is worth noting that PCT and PCF hybrids
clearly do not resemble cultured fibroblasts morphologically.
The tissue type which predominates in poorly differentiated areas
of PCT- and PCF-derived tumors also closely resembles embryonal carci
noma tissue (see Part 3E, below.)
In summary, then, PCT and PCF cells resemble their ECC parent
ultrastructurally, in their phase contrast appearance, and in their
growth habit.

PART 3C:

Alkaline phosphatase levels in PCT and PCF cells

Table 3-3 shows the results of a series of APase determinations
carried out on third-day (near-confluent) cultures of PCT hybrid cells,
together with measurements made at the same time on control materials.
As explained above, these experiments were prompted by the demonstration
of Bernstine et al. (1973) that cultured ECCs, like their counterparts
in teratocarcinoma tumors, had high levels of this enzyme.

To see if

my results could profitably be compared with the values reported by
i- M r

group, I included mouse kidney homogenates in many of the assays,

and found that the value I obtained (31.5 ymol/hr/mg protein; s.e.m.
3.44) was similar to that obtained by Bernstine's group (28.0; range
21.8-38.0).
The specific activities of APase in two ECC lines, F9 and PCC4azal,
are presented in Table 3-3 as well.

These levels are near the lower end

of the range reported to be characteristic of ECC lines, but 10-20 times
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TABLE 3-3

ALKALINE PHOSPHATASE IN PCT HYBRIDS AND CONTROLS

Cell line

Specific Activity

S.E.M.

PCTA1

3.91

0.51

8

PCTA2

3.61

0.50

8

PCTBla

2.09

0.38

8

PCTBlb

2.50

0.38

8

PCC4azal

4.04

0.56

6

F9

5.09

0.53

7

TSD4

0.21

0.04

4

Thymocytes

0.53

0.18

7

31.48

3.44

9

Kidney

Specific activities are given in yMoles p-nitrophenyl phosphate
hydrolyzed/hr at 37°/mg protein.

The values given are

the means and standard errors of the means of N separate
daily preparations.
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M ghpr than the activities found in most other cultured cell lines
(Bernstine et al., 1973).

Data for one non-pluripotent line, TSD4, a

fibroblast ceil line derived from OTT6050 embryoid bodies, is presented
in Table 3-3.

Mouse thymus cells also contain less APase than ECCs.

All four PCT hybrid lines have significantly more APase than either
their thymocyte parents or TSD4; one of the four has significantly less
enzyme than the PCC4azal parents, and the other three have slightly but
not significantly less than their ECC parent (statistical analysis not
shown).

Histochemical experiments showed that nearly all cells in

logarithmic PCC4azal and PCT cultures had detectable amounts of enzyme,
and that the activity was concentrated, as is the case for embryonal
carcinoma cells in tumors (Damjanov and Solter, 1975), at the inter
cellular boundaries.
Table 3-4 shows comparable data for the five PCF hybrid clones.
These results were obtained several months after the ones shown in
Table 3-3, and it is worth noting that the specific activity of the
PCC4azal subline used as a control for the PCF experiments had somewhat
more APase activity than the closely related line I had used earlier.
The divergence in related sublines suggests that small differences in
APase activity between ECC lines, even if statistically significant,
may not be biologically important.

All five PCF clones have as much

or slightly more APase activity than their PCC4azal parent, even though
FBD has no detectable APase.
In summary:

PCT and PCF hybrid cells have high levels of alkaline

phosphatase, an enzyme characteristic of embryonal carcinoma cells.

The

levels in the hybrids are comparable to those of PCC4azal, but much
higher than those of the non-pluripotent parent in each case, and higher
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TABLE 3-4

ALKALINE PHOSPHATASE IN PCF HYBRIDS AND CONTROLS

Cell Line

Specific Activity

S.E.M.

N

PCFA8

9.94

1.37

5

PCFB1

7.22

1.52

5

PCFB2

9.54

0.78

5

PCFB3

10.15

1.41

5

PCFB5

10.88

0.88

5

7.32

1.58

5

---

3

PCC4azal
FBU

<0.1

Specific activities are given in pMoles p-nitrophenyl
phosphate hydrolyzed/hr at 37°/mg

protein.The values

given are the means and standard errors ofthe means of
N separate daily preparations.
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than the levels typical of most other cultured cell types.

PART 3D:

PCT and PCF cells are resistant to infection by the mouse

parvovirus, MVM

As discussed above, Swartzendruber and Lehman (1975) and Lehman
et al. (1975) have shown that embryonal carcinoma cells are resistant
to infection by SV40 and polyoma, two small DNA oncogenic viruses.
These viruses were, however, able to infect differentiated (nonpluripotent) teratocarcinoma-derived cells.

Stimulated by their find

ings, I investigated the interactions of a mouse parvovirus, MVM, with
ECC cultures and other cell lines.

In a collaborative study (Miller,

Ward, and Ruddle, submitted for publication), I established that re
sistance to MVM infection was characteristic of ECCs in culture, but
that teratoma-derived fibroblasts, like most non-teratoma lines
examined, were susceptible to MVM infection.

The immunofluorescent

assay for MVM antigens is illustrated in figure 3-9, which shows that
PCC4azal, unlike A9 (an established mouse fibroblast line), TDla (a
teratocarcinoma-derived fibroblast), and FBU, fails to produce detect
able nuclear antigen upon exposure to MVM virus.

Table 3-5 summarizes

the results of a similar set of experiments in which the effect of
increased viral MOI was quantitated.
PCT and PCF hybrid cells, like their PCC4azal parent, are resistant
to MVM infection.

Each PCT clone was tested in three separate experi

ments, and each PCF clone tested 2-5 times.

Representative areas of

infected and stained cell cultures are shown in figures 3-9e,f.

No

immunofluorescent nuclei were seen in any of the experiments, except
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Figure 3-9

Immunofluorescent detection of MVM intranuclear antigen in PCT
and PCF hybrid cells, and in controls.
a) A9 mouse fibroblast; positive control.
b) TDla; teratocarcinoma-derived fibroblast.
c) PCC4azal; embryonal carcinoma parent.
d)

FBU; Friend erythroleukemia cell parent.

e) PCTA1.
f) PCFB2.

Note that all the cells have a dim cytoplasmic fluorescence (dull
red under the microscope) due to the Evans Blue counterstain.
Some A9, TDla, and FBU cells have, in addition, a bright
nuclear fluorescence (green in the original) due to the presence
of MVM viral antigen.

PCT and PCF cells, like their PCC4azal

parent, do not contain MVM antigen after exposure to virus.
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TABLE 3-5

MVM INFECTION:

Cell Line

PROPORTION OF STAINED CELLS

MOI

2.

S.D.

N

A9

10

.22

.019

501

A9

200

.35

.027

307

.00033

.00033

=3075

.0018

.0005

=7380

PCC4azal

10

PCC4azal

200

TSD4

10

.37

.026

341

FBU

10

.033

.006

947

MOI gives the number of PFU of virus added per cell, assuming that
one population doubling has occurred between subculture and addition of
virus.

Column p gives the ratio of immunofluorescent cells to total cells

examined, and S.D. gives the standard deviation of this number.

N is the

actual number of cells counted for A9, FBU, and TSD4, and the approximate
number scanned for PCC4azal, estimated by counting the cell number in the
first five fields examined, and multiplying by the number of fields looked
at in all.
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that two of the PCT clones, in one of three experiments conducted, had
areas with several positive nuclei.

Each experiment involved the

examination of several thousand cells from each hybrid clone.
MVM is known to require S-phase cells for its proliferation
(Tattersall, 1972).

There was no indication that my conditions of

infection interfered with the cell cycle in the resistant cultures, but,
in order to eliminate this consideration entirely, I tested infected
cultures autoradiographically for the ability to incorporate thymidine
into cell nuclei.

Virus-treated hybrid cells, like PCC4azal cells, were
3

able to accumulate intranuclear

H-thymidine but did not accumulate

viral antigen; A9 cultures tested in parallel had many nuclei which
were both radioactive and fluorescent.
As shown above, FBU cells are susceptible to MVM infection, and
this susceptibility is extinguished in the PCF hybrids.

It is not

meaningful to test mouse thymocytes in the same way, as a control for
the PCT hybrids, since thymus cells do not divide in culture, while MVM
infects only proliferating cells.

Concanavalin-A-stimulated splenic

lymphoid cells, most of which are derived from thymus-processed
lymphocytes (Stobo et al., 1972), were also tested, and were found not
to accumulate MVM antigen.

This is not surprising, considering that

MVM, like other parvoviruses, seems not to interfere with mitotic cell
populations in adult animals (for review, see Toolan, 1972).
In summary:

PCT and PCF hybrids resemble ECCs in that all three

cell types, unlike most permanent mouse cell lines, are resistant to
infection by the parvovirus MVM.

Whatever factors make Friend cells

susceptible to MVM infection are extinguished after hybridization with
the ECC line, PCC4azal.
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PART 3E:

PCT and PCF cells give rise to multidifferentiated tumors,

some of which produce a-fetoprotein.

Each clone of PCT and PCF hybrid cells was tested to see whether
it could produce tumors after subcutaneous inoculation into mice.
after inoculation of as many as

107

Even

cells into genetically appropriate

animals, "take" incidence of some hybrid lines remained low, as is
shown by the data presented in Table 3-6.

A detailed study of those

factors (age and sex of host, size of inoculum, syngeneic vs. nude host,
etc.) which might influence the fraction of successful inoculations was
not carried out.
Tumors were, however, produced from all of the four PCT clones
and from four of the five PCF clones.

Some tumors were produced in

mice homozygous for the gene "nude," which impairs cell-mediated immune
responses (Freedman and Shin, 1974); others were produced in syngeneic
F^ hybrid mice.

Of the three PCT tumors tested, all three were shown

to be transplantable:

pieces of tumor tissue removed at autopsy and

inserted subcutaneously into F^ mice gave rise to progressively growing
tumors.
Cell lines were derived from four of the PCT tumors and tested for
chromosome and isozyme content to see to what extent the tumor cells
resembled the originally inoculated population.

As shown in Table 3-7,

all four tumor-derived cell lines retained GPI heterodimer, and thus
are known to contain at least one chromosome from each of the parental
cell strains.

Three of the four tumor lines had chromosome numbers

indistinguishable from those of the original populations; the other
had lost about 7 of its original 75 chromosomes.

By the end of their

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

103

TABLE 3-6

INCIDENCE OF TUMOR FORMATION BY PCT AND PCF HYBRID CELLS

Cell line

Incidence

PCTA1

4/4

PCTA2

4/6

PCTBla

3/4

PCTBlb

4/9

Total PCT

15/23

PCFA8

'/7'

PCFB1

0/4

PCFB2

1/4

PCFB3

2/4

PCFB5

2/4

Total PCF

8/23

(65%)

(35%)

Tumor incidence is expressed as number of tumors/number of
animals inoculated.

Three tumors produced by transplantation of

PCTBlb primary tumors have been omitted from the data in this
table.
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TABLE 3-7

CHROMOSOME NUMBER AND ISOZYME ANALYSES OF CELL LINES
DERIVED FROM PCT TUMORS

Mean #

S.D.

N

PCTA2

72

4.6

21

73

+

Tll-3

PCTA2

72

2.6

19

73

+

T4-3

PCTBla

68

3.0

19

75

+

943

PCTBlb

75

2.3

21

74

+

Tumor

Cell Line

Tll-2

Orig. #

GPI I

Cultured cells derived from tumors of the indicated hybrid cell lines
were used to prepare metaphase spreads 3-4 subculturings after initiation
of each culture.

N metaphases were counted to yield a mean chromosome

number and a standard deviation (S.D.) for each distribution.

The mean

chromosome number characteristic of the inoculated cell line is also
listed.

The final column indicates the GPI heterodimer was demonstrated

in each tumor-derived population.
Analogous data for PCF-derived tumors is not available.
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second passage la vitro, these tumor-derived cell lines contained only
cells which resembled ECCs (and hence the Inoculated PCT cells)
morphologically.
All the tumors were fixed, sectioned, and stained with hematoxylin
and eosin for histological evaluation.

Table 3-8 presents the results

of the histological analysis of the PCT tumors.

Illustrative histolog

ical sections are presented in figures 3-10, 3-11, and 3-12, as well as
in 3-14c,d.

Because of the lower "take" incidence of the PCF cell lines

(see Table 3-6), fewer PCF-derived tumors were available for analysis;
Table 3-9 summarizes the data from the eight PCF tumors obtained.
Figures 3-13 and 3-14a,b show sections of PCF tumors.
All of the tumors contained embryonal carcinoma, examples of which
are shown in figures 3-10a and 3-13a.

The presence of embryonal carci

noma in hybrid-derived tumors is consistent with the other data sug
gesting that these cell lines resemble their ECC parent, PCC4azal.

The

three PCFA8 tumors were composed entirely of embryonal carcinoma, and
several of the PCT tumors were largely embryonal carcinoma, in which
could be found small islands of differentiated tissue.
All the PCT tumors, and each of the five PCFB2, PCFB3, and PCFB5
tumors contained at least some differentiated tissue.

In general,

tumors with the greatest variety of tissue types also contained the
largest proportion of non-ECCs.

Several of the tumors were largely

necrotic at the time of autopsy, but contained nodules of cartilage;
these tumors are left otherwise undiagnosed (empty spaces) in Table
3-8.
Some tissue types were seen frequently.

All the tumors (except,

of course, those from PCFA8 ) had at least some primitive neural tissue,
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TABLE 3-8

DIFFERENTIATED TISSUES FOUND IN PCT HYBRID TUMORS

CO i—iCM
CO i 1
CO CO CO
E-* H

Tissue

Embryonal carcinoma

CO
1
co
£-<

'S- i— iCM CO
m i 1 1
o\
iH r—I
i—!i— 1 iH
H H H

+ + + +

PCTBlb

PCTBla

PCTA2

PCTA1

CO t“H CM CO <• uo
r-» I 1 1 1 1
3- -d- -C sr
r »f ■ C_I c_f r i
C”» tr*

a\

+ + +

+ +

+

+ +

CM CO I— 1 CM
<- ST 1 1
<S\ m o o
__1 __ 1
H E-i

+

+ + +

Ectodermal cords

- + + +

+ + +

+ + + + t

Primitive neural tissue

+ + + +

+ +

+

Mature neural tissue

- + + +

+ + +

+ - + +

-

+ + + +

Stratified squamous
epithelium

- - - -

- + +

— — — —

—

—

—

+

+

Mesenchyme

-

+

+

-

-

-

-

-

-

-

-

-

-

-

+

-

Muscle

-

+

+

-

-

-

-

-

-

-

-

-

-

-

+

-

Cartilage

-

+

-

+

-

-

+

+

-

-

-

-

-

-

+ +

Endodermal epithelium

+

+

+

-

+

+

-

+

-

-

-

-

+

+

+

+

Ciliated epithelium

-

+

-

-

-

+

-

-

-

-

-

-

-

-

+

+

Glandular structures

-

+

-

-

-

-

-

-

-

-

-

-

-

-

+

Parietal yolk sac

-

+

-

-

-

-

-

-

-

-

-

-

-

-

---

Polyploid giant cells

-

+

-

-

-

-

-

-

-

—

-

-

-

-

+

-

—

—

+

+

a-fetoprotein

+

+

+

+

+

+

JL

- - + +
+

+

+

+

+

-

A (+) sign indicates that the tissue was found in the tumor indicated;
a (-) sign indicates absence.

An empty space in the a-fetoprotein row

shows that no test was carried out for the animal in question.

Tumors

954 and 973 were largely necrotic, but nodules of cartilage were apparent
in each.

All tumors are primary, except that T4-3, T4-4, and T4-5 were

derived from transplantation of T4-2; T4-5 is a second generation transplant.
T-series tumors

ere produced in syngeneic (C3H/HeJ x 129/Sv)F^ mice, and

the others in nu/nu animals.
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Figure 3-10

Hematoxylin- and eosin-stained sections of PCT hybrid tumors.
a)

Typical poorly differentiated area, with an ectodermal cord
at center left.

b)

Tumor 876; xl60.

Well differentiated area.

Note ciliated epithelium (ce),

cartilage (ca), as well as embryonal carcinoma (ec).
Tumor T8-1; xl 8 0 .
c)

Well differentiated area.

Note glandular tissue (gl) and

several endodermal vesicles
tubule at left of center.
d)

Ectodermal cords.

(for example, e n ) .
Tumor T8-1; xl80.

Tumor T4-4; xl80.
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Figure 3-11

Hematoxylin- and eosin-stained sections of PCT hybrid tumors.
a)

Endodermal vesicle.

b)

Ciliated epithelium.

c)

Parietal yolk sac.
arrows.

d)

Tumor 943; xl45.
Tumor T8-1; x440.
Note Reichert's membrane indicated by

Tumor T8-1; x440.

Glandular tissue.

Tumor T8-1; xl80.
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Figure 3-12

Hematoxylin- and eosin-stained sections of PCI hybrid tumors.
a)

Cartilage.

Tumor T4-1; xl80.

b)

Immature muscle.

c)

Neural tubules.

d)

Giant cells.

Tumor T4-1; x440.
Tumor 943; xl80.

Tumor T8-1; x440.
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TABLE 3-9

DIFFERENTIATED TISSUES FOUND IN PCF HYBRID TUMORS

PCFA8
CM CO t—1
"sT 1

o» o
r~. t r i

1~J

fcH

PCFB2
(

PCFB3

i—
■
i
<3t—)

H

r-H
■
i
CO
tH
Eh

<N
■
i
CO
1---(
H

PCFB5
i—1
1
1
CO
CH

CM
I1
CO
c_j
CH

Tissue

Embryonal carcinoma

+ + +

+

+ +

+ +

Ectodermal cords

---------

--

+

+ +

~

Primitive neural tissue

----------------

+

+ +

- +

Mature neural tissue

--- --

+

+ —

- -

Cartilage

--- --

+

+ +

+ +

Muscle

-----

+

+ +

~ +

Endodermal epithelium

-- --

-

+ +

+ +

Ciliated epithelium

- - -

+

+ +

+ ~

a-fetoprotein

-- --

-

---

+

A

(+) sign indicates that the tissue was present in the

sign denotes absence.
T3-2.

+

No test for a-fetoprotein was performed on animal

Tumors 1042 and 1043 were produced in nu/nu mice, and all others

in syngeneic (DBA/2J x 129/Sv)F^ animals.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 3-13

Hematoxylin- and eosin-stained sections of PCF hybrid tumors.
a)

Embryonal carcinoma cells.

T7-1; xl75.

b)

Cavities lined with ectodermal epithelium, with embryonal
carcinoma at lower left and primitive neural tissue in
the central band.

c)

T3-1; xl75.

Cavities lined with ciliated endodermal epithelium.
T13-1; x430.

d)

Primitive neural tissue with organized neural tubules.
T 13-1; x430.
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Figure 3-14

Hematoxylin- and eosin-stained sections of PCT and PCF hybrid tumors.
a)

Rhabdomyosarcoma tissue in

a PCF tumor.

b)

PCF tumor with cartilage nodule,

T13-1;

xl75.

rhabdomyosarcoma tissue

around it, and primitive neural tissue at right, above
center.
c)

T13-1; xl75.

Stratified squamous epithelium, with transition to ciliated
epithelium, and with a vesicle of ciliated epithelium
above; from a PCT tumor.T10-1; x430.

d)

Mature neural tissue, from

a PCT tumor.

HO-1;
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which in some cases made up nearly all the bulk of the tumor.

Organiza

tion of this tissue into neural tubules (figures 3-12c, 3-13d) was
common.

Mature neural tissue (figure 3-14d)» cartilage nodules

(figures 3-10b, 3-12a, 3-14b), cavities lined with endodermal epithelium
(figure 3-lla), and cords of ectodermal epithelium (figures 3-10d,
3-13b) were present in many of the tumors.

Some tissue types, including

ciliated and secretory endodermal epithelium (figures 3-10b, 3-llb,
3-13c), stratified squamous epithelium (figure 3-14c), parietal yolk
sac with Reichert's membrane (figure 3-llc), and glandular structures
(figure 3-lld), were present only in the well-differentiated tumors.
Bone and pigmented tissue were not observed; these tissues are common
in primary teratomas, but considerably less so in transplantable
teratocarcinomas which have been passaged for many generations (L. C,
Stevens, personal communication).
Scoring for mesodermal derivatives in these tumors is difficult.
Cartilage is easy to recognize, and cannot be confused with host tissue.
Confident diagnosis of muscle and connective tissue is, however, tricky
in poorly differentiated tumors when they are enmeshed in host connec
tive tissue and subcutaneous muscle.

As a consequence, my scores for

these two sorts of tissue are most likely underestimates.

I accepted

mesenchyme and muscle tissue as tumor-derived only when I found them
isolated from the strands of penetrating host tissue; most such areas
were close to areas of cartilage.

Some areas of muscle tissue (figure

3-12b) resembled immature cardiac muscle, and are thus unlikely to
have been host-derived.
PCF (though not PCT) tumors contained large amounts of the tissue
shown in figure 3-14a.

These large, pleomorphic, multinucleated cells
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were usually found near cartilage nodules, and resemble (L. C. Stevens,
personal communication) cells found in rare teratocarcinomas undergoing
transition into rhabdomyosarcomas. All four PCF tumors diagnosed in
Table 3-9 as having muscle tissue had this unusual kind only.
Most of the tumor-bearing mice were bled just prior to sacrifice,
and their sera analyzed for the presence of a-fetoprotein (AFP). Figure
3-15 presents an example of such an experiment, and the results of the
analyses are given as the last lines in Tables 3-8 and 3-9.

Three of

the 13 PCT tumors tested, and one of 7 PCF tumors, produced detectable
amounts of AFP; all four of the positive tumors were well-differentiated
and contained substantial amounts of secretory endodermal epithelium.
As discussed above, the best evidence suggests that AFP is not synthe
sized by ECCs, but rather by endodermal derivatives, including visceral
yolk sac.

The good correlation in these hybrid tumors between AFP

secretion and the presence of endodermal derivatives adds further
support to the hypothesis that these differentiated cells are responsible
for AFP production in teratomas.

The presence of AFP in the sera of

tumor-bearing mice suggests that structural differentiation in the
hybrid cells was accompanied by appropriate functional changes.

PART 3F:

PCT cells lack Thy-1 (theta) antigen

Thy-1 antigen (previously called "theta") is an alloantigen first
defined on thymocytes (Reif and Allen, 1964a,b), and subsequently
demonstrated to be present on some brain cells, epidermal cells, thymusprocessed lymphocytes (for review, see Greaves et al., 1973) and some
fibroblast lines (Stern, 1973).

ECCs do not have Thy—1 antigen
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Figure 3-15

Discontinuous counterimmunoelectrophoretic detection of a-fetoprotein.
Top row:

rabbit antiserum to mouse a-fetoprotein, diluted 1:4.

Bottom row:

Antigen:

serum or ascitic fluid from a mouse

carrying the indicated tumor; diluted 1:4.

1)

T8-3

2)

T7-1

3)

OTT 6050 embryoid bodies

4)

T3-1

5)

971 (nude mouse carrying a fibrosarcoma hybrid tumor;

(ascitic fluid; positive control.)

negative control.)
6)

OTT 6050 embryoid bodies

7)

T10-2

8)

T13-2

9)

T13-1

(serum; positive control.)

Wells 3, 4, 6, and 7 are positive for a-fetoprotein.
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detectable by immunofluorescence (Stern et al., 1975).

As mentioned

above, Thy-1 antigen has been shown to be extinguished when normal
thymocytes (Parkaan and Merler, 1973) or thymic leukemia cells (Liang
and Cohen, 1975) have been hybridized with Thy-1

fibroblasts.

PCT hybrid cells were examined for Thy-1 alloantigen by a cyto
toxic absorption test.

Since both 129/Sv and C3H/HeJ animals carry

the Thy-1^ allele, which produces Thy-1.2 antigen, an AKR/J-antiC3H/HeJ thymocyte serum, produced and titred as described above, was
used in a cytotoxic absorption test (see Part 2K) using C3H/HeJ
thymocytes as target cells.
3-10

Each PCT clone was tested 5 times; Table

shows the result of a representative experiment.
Each aliquot of absorbed serum was divided into two portions,

which were then tested independently for cytotoxic activity.

In the

experiment presented in Table 3-10, the two portions of AKR/J-thymocyteabsorbed serum killed 792 and 802 of the 100 cells counted.
records the mean of these
error of the mean.

"2

The table

killed" scores, as well as the standard

The cytotoxic index, calculated as described in

Part 2K above, shows that AKR-absorbed serum killed 792 of the
thymocytes excluding those killed by C' alone; the value of 902 residual
cytotoxicity indicates that this AKR-absorbed serum had a cytotoxic
index 902 of that for unabsorbed serum tested on the same, day.
The table shows that (C3H/HeJ x 1 2 9 / S v ) m o u s e thymocytes, as
expected, removed all of the Thy-1 cytotoxic activity from the serum.
Three of the PCT hybrid clones removed about as much activity as did
AKR thymocytes; the fourth clone, PCTBla, removed somewhat more in this
particular test, though not in replicate experiments.

All four PCT

clones repeatedly removed small amounts of cytotoxic activity, usually
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TABLE 3-10

CYTOTOXIC ABSORPTION TEST FOR THY-1.2 ANTIGEN

Mean
% Killed

Absorbed With

S.E.M.

Cytotoxic
Index

Residual
Cytotoxicity

AKR/J thymocytes

79.5

0.5

79

90

C12F^ thymocytes

4.5

0.5

0

0

PCTA1

77.0

3.0

76

86

PCTA2

80.0

3.0

79

90

PCTBla

54.5

5.5

52

59

PCTBlb

80.5

1.5

80

91

Unabsorbed serum

89.0

1.0

88

4.5

2.5

(0)

No serum; C' only

(100)

Two volumes of serum diluted 1:1600 were absorbed with one
volume of packed cells.
in the text.

Further experimental details are given

'Talues in parentheses are assigned by definition.

= (C3H/HeJ x 129/Sv)Fr
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to about the sane extent as did AKB/J thymocytes.

Since AKR/J mice

£
carry the Thy-1 allele, and are hence unable to produce Thy-1.2
antigen, the small amount of antibody they absorb from the serum is
likely unrelated to the Thy-1 system.

(The antiserum was not produced

in congenic mice, and thus may very well include antibodies specific
for other antigens.)

It is possible that the PCT cells exhibit a very

small amount of Thy-1.2 antigen, or, more likely, that they absorb
small amounts of the other specificities detected by the AKR-anti-C3H
serum.

They clearly produce much less Thy-1 antigen than thymus cells

from hybrid mice.
Dr. K. Kano (S.U.N.Y., Buffalo, N.Y.) has also tested these cells,
in his laboratory and using different antisera, for the presence of
Thy-1.2 antigen.

Neither PCC4azal nor any of the four PCT clones had

Thy-1 antigen detectable either by absorption or mixed hemagglutination
tests.

PART 3G:

PCT cells exhibit H-2 antigens

Although most mouse cells, including thymocytes, exhibit H-2
antigens on their surface (for review, see Klein, 1975), embryonal
carcinoma cells are said not to; antibody-mediated cytotoxic tests
(Artzt and Jacob, 1974) and immunofluorescence (Stem et al., 1975)
have both been shown not to detect H-2 on ECCs.

The PCT hybrid clones

and their PCC4azal parent were therefore tested to see whether they
could absorb cytotoxic anti-H—2 antibodies.

Since the parental genomes

differed at the H-2 loci (129/Sv carries haplotype be, which is serol
ogically indistinguishable from b, and C3H/HeJ carries haplotype k),
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it was possible to look for the independent expression of H-2 genes
from either genome.

The antisera used and the procedure employed have
|)C

been discussed above; as susaaarized in Table 2-1, the test for H-2
utilizes a serum directed against the private specificity, 33, shared
by the

and K?*c antigens (as well as against several public speci-

ficities not present on K

or D ;, while the anti-H-2

test employs a

serum which will react against the private specificity, 23, present on

It
the K

molecule, and against several public specificities.
Table 3-11 presents the results of several experiments in which

the anti-H-2

serum was absorbed with 0.5 volumes of packed PCT (or

control) cells, and then split into two portions which were tested on
810.BR mesenteric lymph node cells for residual cytotoxic activity.
Unabsorbed serum, by definition, had a residual cytotoxicity of 100.
Serum absorbed with A9 cells (transformed C3H/HeJ fibroblasts; H-2^)
had a residual cytotoxicity of

6

(data not shown). As expected,

PCC4azal and F9 cells do not absorb H-2
do not carry this haplotype.

antibodies, since these cells

All four PCT hybrid cell lines absorb

significant amounts of anti-H-2

cytotoxic activity.

The rightmost

column of Table 3-11 shows the result of a statistical test of the
hypothesis that the cell line in question absorbs the same amount of
cytotoxic activity as PCC4azal.

As evaluated by Student's t-test

(Snedecor and Cochran, 1967), all four PCT cell lines differ from
PCC4azal in this respect, at the p<.01 significance level.

Furthermore,

although the 95% confidence intervals for mean residual cytotoxicity
include 100 for F9- and PCC4azal-absorbed serum, the intervals for
three of the four PCT hybrid lines do not include 100; this data is
also included in Table 3-11.

(The first of these tests is the more
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TABLE 3-11

H-2

Cell Line

ANTIGEN IN PCT HYBRID CELLS AND CONTROLS

Mean RC

S.E.M.

95% Limits

N

t-statistic
(vs. PCC4azal)

PCC4azal

107

7

77-137

3

F9

109

14

49-169

3

.12

PCTA1

17

7

0-47

3

9.14**

PCTA2

27

7

0-57

3

8.28**

PCTBla

20

10

0-147

2

7.86**

PCTBlb

3

4

0-20

3

13.56**

For each cell line, the results of N separate assays (each involving
duplicate determinations) were averaged to give a mean residual cytotox
icity (Mean RC), which is a cytotoxic index expressed as a percentage of
that found for unabsorbed serum in the same test.

S.E.M. gives the

standard error of this mean, and the limits of the 95% confidence interval
for the mean are also given.

The rightmost column shows the t-statistic

computed to test the hypothesis that the cell line in question differs from
PCC4azal in Mean RC.

(**) indicates that all four PCT clones differ from

PCC4azal in this respect at the p<.01 confidence level.
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convincing, since the absorption of snail but significant amounts of
activity could be ascribed to serum dilution by diluent trapped in the
cell pellet, or to non-specific binding; but these effects, if present,
are likely to have affected negative control cells as well.)

On

average, the unabsorbed antiserum, at the dilution used, killed about
70% of the target cells in these tests; PCT absorbed sera, on average,
killed about 20-30% of the B10.BR targets.

When these values are

compared to the titration curve for D3b serum (not shown), one finds
that PCT absorption removes between 50-70% of the cytotoxic antibody.
Since the largest portion of antibody in D3b serum seems likely to be
directed against classical H-2 antigens (and not, for example, la
antigens), we can conclude that PCT cells probably exhibit K^.
The expression of H-2

antigens on the surface of cells of all

four PCT clones has been confirmed by K. Kano using a mixed hemaggluti
nation technique (K. Kano, personal communication).
Table 3-12 presents the results of similar tests for H-2
antigen.

Three control cell lines were tested:

be

A9 and FBU do not

be
carry the genes for H-2
antigens, and F9, though from a 129/Sv mouse,
has been shown not to express H-2 antigens (Artzt and Jacob, 1974).
As expected, the 95% confidence interval for the mean residual cytotox
icity of each line includes 100; F9-absorbed serum, in three tests,
retained 95.7% (±2.8% standard error of the mean) of the cytotoxic
activity present in unabsorbed serum tested at the same time.
PCC4azal, and three of the PCT hybrid clones, absorbed statistical
ly significant (though very small) amounts of cytotoxic activity from
D33 antiserum tested on C57BL/10 mesenteric node lymphocytes; the 95%
intervals for these three cell lines do not include 100.

PCTA1 and
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TABLE 3-12

H-2b ANTIGEN IN PCT HYBRID CELLS AND CONTROLS

Cell Line

Mean RC

S.E.M.

95% Limits

N

t-statistic
(vs. F9)

103

3.5

59-147

2

FBU

98

6.6

77-119

4

--

F9

96

2.8

84-108

3

--

PCC4azal

83

4.9

69-97

5

1.81

PCTA1

71

3.4

56-86

3

5.50**

PCTA2

76

8.3

40-112

3

2.18

PCTBla

76

5.0

60-92

4

3.17*

PCTBlb

84

4.6

69-99

4

1.95

A9

For each cell line, the results of N separate assays (each involving
duplicate determinations) were averaged to give a mean residual cytotox
icity (Mean RC), which is a cytotoxic index expressed as a percentage of
that found for unabsorbed serum in the same test.

S.E.M. gives the

standard error of this mean, and the limits of the 95% confidence interval
for the mean are also given.

The rightmost column shows the t-statistic

computed to test the hypothesis that the cell line in question differs from
F9 in Mean RC.

(**) indicates significance at the p<0.01 level;

(*), at the p<0.05 level.
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PCTBla absorbed more antiserum than negative control F9 cells, as
tested by Student's t-test, at the levels of significance indicated
in the table.

The other two PCT lines and PCC4azal may have absorbed

more antibody than F9 cells, but not significantly more.
When changes in the proportions of target cells killed are compared
with the titration curve for this cytotoxic system, it is clear that
absorption with PCT or PCC4azal cells removes less than half of the
serum's cytotoxic activity.

It seems possible, therefore, that the

antibodies removed by these cells could be "contaminating" molecules
not directed against the classical H-2 antigens themselves.
perspective, what seems to be low-level expression of H-2

be

From this
might re

flect the limitations in specificity of our cytotoxic system.
PCT and PCC4azal cells are pluripotent; PCT cultures, especially,
sometimes contain small clusters of morphologically differentiated
cells.

It is possible that a small proportion of the cells in the

cultured populations exhibit H-2
this antigen.

be

, but that the majority of cells lack

Small amounts of H-2

be

have been demonstrated on PCC4

cells under some culture conditions (K. Artzt, personal communication).
Heterogeneity of antigen expression in these cells could be evaluated
by immunofluorescence.
PCT cells absorb more cytotoxic activity from the anti-H-2
than from the anti-H-2^ serum.
actually express more H-2

k

serum used

Although it is possible that these cells

product (from the thymocyte genome) than H-2

be

(from the teratocarcinoma genome), the tests presented in this thesis do
not prove this.

The two sera may, for example, differ in a) the number

of different antigenic determinants recognized; b) the concentrations
of antibody specific for each determinant; and c) the distribution
of cytotoxic activity among the individual antibody species.
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It is also possible that tke two target cell
in susceptibility to C'.

populations might differ

It is thus impossible to infer a simple re

lation between mean residual cytotoxicity values and numbers of H-2
molecules produced by the absorbing cell.
Two of the PCF lines (PCFA8 and PCFB2) absorb significant amounts
of anti-H-2^ activity as well, but these lines have not been studied
as extensively, and the data will not be presented here.

PART 3H:

PCF cells resemble PCC4azal enzymatically

FBU and PCC4azal cells differ in their levels of two enzymes
(besides alkaline phosphatase, which has been discussed above):

FBU

cells have high levels of acetylcholinesterase (E.C. 3.1.1.7; AChE),
and PCC4azal cells express the "B" allele of lactate dehydrogenase
(E.C. 1.1.1.27; LDH), as well as the LDH-A allele (which both parents
express). All five PCF clones resemble PCC4azal in both respects.
Auerbach and Brinster (1967) have reported that pre-implantation
mouse embryos, from the oocyte stage to that of the 5th-day blastocyst,
contain LDH-1 (i.e., only B subunits) to the virtual exclusion of the
other LDH isozymes (which contain some of the A subunit).

Shortly after

implantation, however, the LDH pattern changes radically, so that by
day 7, and until day 12, 90% of the LDH in the embryo and its protective
membranes is LDH-5, which contains only A subunits.

When implantation

is delayed hormonally, the changeover in LDH pattern was similarly
delayed, although the blastocysts were not otherwise damaged and re
tained the ability to implant when the hormonal treatment was over.
This result suggests that the synthesis of LDH-A subunits is linked to
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Implantation per se.
As shown in figure 3-16, PCC4azal cells synthesize both LDH-A and
LD5-B, and, in this respect, resemble neither cells of pre-inplantation
embryos nor of the early post-implantation stages.

The LDH pattern of

embryonal carcinoma cells other than those long since adapted to
culture has not, to my knowledge, been reported.
FBU cells, as shown in figure 3-16, express only LDH-A.

PCF

hybrid cells, like PCC4azal, express both A and B alleles, though more
A than B is produced by both the hybrid and parental cells.
Acetylcholinesterase is present in erythroid cells, including
mature erythrocytes (Galehr et al., 1928) and Friend erythroleukemia
cells (Conscience et al., submitted for publication). As shown in
Table 3-13, PCF hybrid cells and PCC4azal ECCs contain less than 1% of
the AChE activity found in the FBU parents.

PART 31:

Globin gene expression in PCF hybrid cells

Many groups (see review in Friend et al., 1974) have shown that
cultures of most Friend erythroleukemic cell lines have levels of
globin mRNA which, while low in comparison to the levels found in DMSOtreated cultures, are much higher than the amounts present in nonerythroid cells.

Uninduced Friend cell cultures also typically contain

a proportion of hemoglobinated, and hence benzidine-positive cells.
This fraction varies between 0.1-5.02; the factors responsible for the
variation are not understood.

FBU cultures assayed at different times

and in different labs have been shown to contain between 0.00022-1.0%
benzidine—positive cells (Skoultchi, Conscience, and Fournier, personal

‘•a>n w >
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Figure 3-16

Lactate dehydrogenase isozymes in PCF hybrids and controls.
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TABLE 3-13

ACETYLCHOLINESTERASE IN PCF HYBRID CELLS AND CONTROLS

Cell Line

FBU

Mean
Specific Activity

3900.

S.E.M.

20.

PCC4azal

13.1

20.9

PCFA8

-1.6

2.1

PCFB1

5.3

1.8

PCFB2

26.0

1.0

PC^BS

9.1

2.9

PCFB5

6.8

1.3

Specific activities are given in pmoles acetylcholine hydrolyzed
per minute at 20° per mg protein, and represent the mean of 2 assays,
each done in duplicate on different days.
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communication, and my own unpublished results). Uninduced FBU cultures
also contain immunologically detectable hemoglobin, and globin mRNA as
measured by nucleic acid hybridization (Skoultchi eit al., submitted
for publication).
The most sensitive of these tests for globin gene expression is
the assay for globin mRNA.

Preliminary results from a collaborative

study (Skoultchi, Miller, and Ruddle, in preparation) show that all five
PCF clones contain globin mRNA, in amounts which are much lower than
those characteristic of FBU cells, but higher than the (undetectable)
levels of Friend cell x fibroblast and Friend cell x hepatoma hybrids.
PCC4azal cells contain little or no globin message.

Growth of PCF cells

in DMSO causes a small diminution of globin mRNA levels.
To rule out the suggestion that these low globin mRNA levels might
be the product of a small proportion of hemoglobinated cells in an
otherwise "non-erythroid" population, I have examined all five clones
of PCF cells, without prior DMSO treatment, for the presence of
benzidine-positive cells.

In excess of 105 cells of each clone were

scanned, and no hemoglobinated cells were found.

FBU cultures tested

as positive controls were found to contain positive cells.

After four

days of growth in medium containing 1.52 DMSO, FBU cultures typically
contain about 45% hemoglobinated cells.

PCFA8 and PCFB5 cultures, on

the other hand, were found not to contain any positive cells (<10~"*)
after four days of growth in DMSO.
The mRNA data, together with the benzidine assays, suggest that
many of the cells in each PCF clone may be expressing the globin gene
at a very low level.

More extensive control studies, particularly to

see if globin mRNA is produced at all in PCC4azal and PCT hybrid cells,
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are in progress.

Regardless of their outcome, it is clear that globin

gene expression in PCF hybrids is severely depressed in comparison to
expression in the Friend cell parent.

PART 3J:

Summary of results

1 summarize here, for convenience, the properties of the PCT and
PCF hybrid cell lines, and compare them with those of the parental cell
lines.

Table 3-14 pertains to the PCT series, and Table 3-15 to the

PCF cells.
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TABLE 3-14

SUMMARY:

PROPERTIES OF PCT HYBRID CELLS AND CONTROLS

PCC4azal

Thymocytes

PCT Hybrids

Chromosome number

39

40

73-75

Growth

attached clumps

suspension

attached clumps

Extranucleolar
heterochromatin

very little

moderate

very little

Alkaline phosphatase1

4 units

2-4 units

MVM infection

resistant

0.5 units
b

Tumors

teratoid

Thy-1 antigen

no

yes

no

H-2

(note c)

? present

not present

present

H-2^

(note c)

not present

present

present

Property

Notes:

resistant
teratoid

(2 clones)

a)

Chromosome numbers and enzyme activities are means.

b)

Thymocytes could not be tested for MVM susceptibility since they do not divide
mitogen-stimulated T lymphocytes are, however, resistant to MVM.

c)

H-2 levels are estimated from massive absorptions, and require further
exploration by single cell technqiues and quantitative absorptions,
as noted in the text.
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TABLE 3-15

SUMMARY:

PROPERTIES OF PCF HYBRID CELLS AND CONTROLS

PCC4azal

FBU

PCF Hybrids

Chromosome number

39

39

70-73 or 94-107

Growth

attached clumps

suspension

attached clumps

Extranucleolar
heterochromatin

very little

moderate

very little

Alkaline phosphatase

7 units

<0.1 unit

7-11 units

MVM infection

resistant

susceptible

resistant

Tumors

teratoid

erythroleukemia

teratoid

LDH Isozymes

A and B

A only

A and B

Acetylcholinesterase

13 units

3900 units

0-26 units

Benzidine stain

negative

positive

negative

Property

Note:

Chromosome numbers and enzyme activities are means.

CHAPTER FOUR:

DISCUSSION

The results of my research, which have been summarized in Part 3J
above, show that somatic cell hybrids of embryonal carcinoma cells can
closely resemble their ECC parent, even to the retention of pluripotency.

Yet experiments in other laboratories, especially the studies

of Finch and Ephrussi (1967), Jami et al. (1973), and McBuraey (1976),
have shown that teratocarcinoma x fibroblast hybrids resemble fibro
blasts (see Part 1G, above).

How can one explain this apparent dis

crepancy?
Four classes of explanation come to mind.

For one thing, PCT and

PCF hybrid cells differ from previously studied teratocarcinoma-derived
hybrids in the proportion of chromosomal material contributed to the
hybrid by the teratoma and non-teratoma parents.

This "gene dosage"

effect on hybrid phenotype has been discussed in Part 1A, above.

The

three parental cell types used to produce PCT and PCF hybrids have 39
or 40 chromosomes each, with 40-43 chromosome arms.

The fibroblast

parents used in the three previous published reports contained 50-68
chromosomes, many of them bi-armed (in the L cell derivatives).

It

would be interesting in this regard to produce and test hybrids between
PCC4azal and tetraploid Friend cells, or between PCC4azal and two
Friend or thymus cells.

As mentioned above, McBurney (1976) has shown

that fusion between a tetraploid ECC and a subtetraploid 3T3 cell
yields fibroblastoid hybrids.
A second possibility is that L cells and 3T3 cells, during their
long history of growth in vitro, may, in the process of selection for
fast-growing cells, have also acquired an unusually strong ability to
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control the phenotype of somatic cell hybrids.

Mere tumorigenicity is

not sufficient to endov a cell with thin (so far hypothetical) ability:
Friend cells (including FLC, the line from which FBU was derived) are
tumorigenic.

It is possible that extensive karyotypic evolution is

more important than tumorigenicity per se.
The discrepancy between my results and the earlier findings might
also be due, in part, to technical considerations.

It is difficult to

tell whether the cloned, pluripotent teratocarcinoma cultures used in
some of the previous studies may have contained "contaminating"
teratoma-derived fibroblasts, as do many such cultures (Lehman et al.,
«

1974; Martin and Evans, 1974).

In my experience, embryonal carcinoma

cultures have seemed to produce hybrids in low yield, relative to other
cultured cell types, and it is possible that fibroblasts in a mixed
teratocarcinoma culture might give rise to hybrid clones at rates
disproportionate to their representation in the culture.

Furthermore,

the hybridizations reported by Finch and Ephrussi (1967) and by Jami
et al. (1973) were carried out under semi-selective conditions; embry
onal carcinoma cells were not killed, and hybrid colonies were selected
for study because they contained fibroblastoid cells.

It is possible

that these two hybridization experiments produced pluripotent hybrids
which were not recognized because they, like PCT and PCF cells, looked
like their ECC parents under phase microscopy.

(Similarly, it is

possible that the PCC4azal x thymocyte fusion mixtures contained hybrid
cells which so closely resembled thymocytes that they failed to grow
under routine culture conditions.

This possibility is in no way ruled

out by my failure to recover proliferating suspension cells.)

These

considerations are unlikely to apply to the study of McBumey (1976),
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who used ECC lines derived by a technique, cloning on feeder layers,
which minimizes differentiation (Martin and Evans, 1975a), and used
selective conditions which killed both parental lines.
A more intriguing explanation of the results reported in this
thesis might be that differences between PCT and PCF hybrids and the
teratoma-fibroblast hybrids are due not to gene dosage, or peculiarities
of culture-adapted lines, or technical artifact, but rather to inherent
differences between fibroblasts and Friend or thymus cells.

The first

step in exploring this suggestion is to ascertain whether any or all
of the products of fusion between ECCs and normal diploid fibroblasts
are pluripotent.

If they are, then the results reported from other

laboratories can be attributed to one or more of the three factors
listed above.

But if hybrids between ECCs and diploid fibroblasts do

resemble their fibroblast parents, this will suggest that fibroblasts
may differ from both Friend cells and thymocytes in the details of the
mechanisms they use to maintain their respective differentiated states.
This suggestion could be explored by cell fusion experiments in which
fibroblasts were compared with Friend and thymus cells with respect
to their aptitude for influencing hybrid phenotypes in confcination with
parents other than embryonal carcinoma cells.
We must also consider the idea that the PCT and PCF hybrids might
resemble teratocarcinomas only because they may have lost large or
particularly important parts of the genetic material contributed by the
non-pluripotent parent.

Several previous experiments (reviewed in

Darlington and Ruddle, 1975) have suggested that retention or re
acquisition of a cell-specific characteristic may be contingent on the
loss of chromosomes from the parent which did not show the trait in
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question; in at least two instances (Wiener et al., 1972; Cochran
et al., 1975), tumor morphology was affected in this way.

It is

possible that each PCT line, for example, could have lost a small number
of thymocyte-derived chromosomes which, if retained, would have forced
retention of thymus-specific traits, but which do not include the
chromosomes coding for GPI or H-2.

It is also conceivable that a large

number of thymus-derived chromosomes have been lost, but have been re
placed by morphologically indistinguishable PCC4azal chromosomes.

These

matters cannot be decided with available genetic or cytogenetic methods.
The three 2:1 PCF hybrids do lose chromosomes with continued culture;
there is no evidence from these clones on the issue of preferential
loss of genetic material from one parent or the other.
Cultured cell lines derived from PCT hybrid tumors show chromosome
loss ranging from moderate (in one tumor, 7 of 75 chromosomes lost) to
undetectable in the other three tumors examined.
tained both alleles of GPI.

All four tumors re

There is thus no evidence, at this limited

resolution, for chromosome loss accompanying tumor formation in PCT
hybrid cells.
My studies of the properties of PCT and PCF hybrid cells suggest

a generalization:

that fusions between embryonal carcinoma cells and

near-diploid non-pluripotent cells produce hybrids which resemble ECCs.
This hypothesis clearly requires further testing; hybrids involving
other ECC lines and other differentiated cell lines should be charac
terized to define the limits over which this generalization applies.
Should this phenomenon prove to be general, it would suggest that
ECCs, and perhaps the embryonic mesectodermal precursor cells they so
closely resemble, contain a molecular apparatus able to "reset" the
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genome of committed and differentiated cells.

Precedent for such a

phenomenon can be found in the work of Gordon and his collaborators
(reviewed la Gordon, 1974), who showed that differentiated amphibian
nuclei could, if placed into an enucleated oocyte, revert to a totipo
tent state and carry out the normal developmental program.

Similar

work has been carried out by Ulmensee (1973) in Drosophila.

The work

presented in this dissertation is not completely analogous, since the
PCC4azal nuclei have not been removed, nor the Friend and thymus cell
nuclei shown to be entirely reprogrammed.

It is possible, for example,

that the Friend and thymus cell genetic material in these hybrids,
while no longer making any of the gene products characteristic of these
cell types, and while still producing the constitutive enzymes and
antigens I have tested for, is for some reason incapable of making ECCspecific products.

Nor have Friend or thymus cell chromosomes been

shown to participate directly in the developmental transitions of which
these hybrids are capable.

These results therefore raise a number of

questions:
1) Do the thymic and erythroid genomes "convert" to pluripotency,
or are they merely neutralized, expressing only those genes which are
expressed in both parents?
2) If PCC4azal cells can reset other genomes, how, in molecular
terms, is this accomplished?
a differentiated nucleus?

Is PCC4azal cytoplasm sufficient to reset

Is a PCC4azal nucleus sufficient to reset

the cytoplasm from some other cell type, and, if so, does this depend
on the position of either parent in the cell cycle?
3) Is this reprogramming ability, hypothesized to be present in
PCC4azal cells, present in all embryonal carcinoma cells, and in
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embryonic oesectodermal precursor cells?

If so, when is it lost:

be

fore, or after the pluripotent ECC commits Itself to a particular line
of differentiation?
These problems have still to be resolved.

In any case, these

experiments show that embryonal carcinoma cells, although nearly unre
stricted in their developmental potential, can nonetheless control the
pattern of gene expression in a somatic cell hybrid whose other parent
is a stably differentiated cell.

The ability (of ECCs) to give rise

to a variety of differentiated progeny under appropriate developmental
conditions does not necessarily bring with it a susceptibility to what
ever factors those differentiated cells use to maintain their epigenetic
state.
The work reported here bears upon three other, more specific issues
as well.

I want first to discuss the relevance of my work to extinction

of Friend cell properties in somatic cell hybrids.

As summarized above

in Part 1C, the previous work on Friend cell hybrids is equally compat
ible with either of two hypotheses:

first, that erythroid properties

are extinguished whenever Friend cells are fused with non-erythroid
cells; or, second, that extinction takes place whenever the non-erythroid
parent contributes the majority of chromosomes to the hybrid cells.

(It

may well be, of course, that total chromosome number is less important
than the doses of a few particular loci.)

PCFB3 and PCFB5 are likely

to contain about equal genetic contributions from FBU and PCC4azal, but
resemble the latter parent closely.

In at least this case, then,

addition of but a single diploid genome from a non-erythroid cell is
sufficient to extinguish the erythroid-specific properties of FBU.

It

is hard to predict the properties of hybrids containing twice as much
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genetic material from Friend cells as from an ECC.
My results are relevant also to the question of antigen expression
on ECCs.
!

j

|
I
!

Previous studies, reviewed in Part IF, have suggested that

ECCs lack detectable H-2 antigen, but exhibit ECC-specific antigen or
antigens, one of which

(F9 antigen) is chemically similar to H-2

and probably coded for

by an allele of the T/tcomplex.

Ideally, one

would wish to characterize the surface antigens of the PCT and PCF
hybrids in a number of ways, including 1) massive absorptions to test
whether the hybrid populations had any cell surface H-2 antigen; 2)flu
orescent antibody tests to see whether all the cells exhibit the same
antigens; 3) quantitative absorptions to see how much of each antigen
was present, expressed relative to a standard absorbing cell, such as
a lymph node cell from an F^ hybrid mouse; and
specific antigens.

At

4)

present, only the first of

testsfor ECCthesesteps hasbeen

completed, and only for the PCT cells; conclusions about surface anti
gen patterns of these hybrids are therefore necessarily limited.
The data show that all four PCT hybrid populations can absorb
cytotoxic activity directed against the H-2
thymocyte parent.

1c

allele contributed by the

Three of the four clones, and PCC4azal cells as

b
well, also remove cytotoxic activity from an anti-H-2 serum, and two
of the PCT hybrids removed significantly more than a negative control
line, F9.

(H-2*5 is serologically indistinguishable from H-2^c , the

antigen of the 129/Sv strain from which the ECC line was derived.)
More cytotoxic activity is removed from the anti-H-2
the anti-H-2^ serum.

serum than from

As discussed above (Part 3K), this result suggests

that these cells may exhibit more H-2

It

molecules than H-2

bo

, but other

explanations are possible and have not been ruled out.
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The results suggest as veil that expression of H-2 antigen is
compatible with pluripotency.

But another hypothesis, that some of

the cells in each hybrid population have begun to express H-2 while
losing pluripotency, can only be ruled out by single-cell tests for
population heterogeneity.
The third specific issue I want to discuss concerns the co-ordina
tion of properties usually expressed together on embryonal carcinoma
cells.

Among the many events that occur during the seventh day of mouse

embryonic development, three seem especially relevant here.

Ectopically

transplanted embryos are able to produce teratocarcinomas only up to
the seventh day of gestation; transplantation of older embryos produces
only embryomas, devoid of ECCs and hence not transplantable from animal
to animal (Damjanov et al., 1971c).

Secondly, early embryos placed

under the kidney or testis capsules develop more or less normally only
up to the seventh day stage, at which point disorganization begins,
culminating in teratoma formation (Stevens, 1968; 1975).

Finally, this

stage is also the earliest at which H-2 antigen can be defected (re
viewed in Billington and Jenkinson, 1975).

Although these three changes

occur approximately at the same embryonic stage, it has yet to be shown
that they in fact take place simultaneously.

One ought, however, to

consider the possibility that these transitions do occur together, and
do so for a reason.
Embryonal carcinoma cells have a cluster of properties, each of
which is found in few if any other cell types.

As discussed in the

introduction to this dissertation, ECCs are a) totipotent; b) nontumorigenic in one environment, the inner cell mass, but able to produce
tumors elsewhere; c) low in H-2 antigen but high in chemically similar,
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ECC-specific antigens; and d) resistant to a number of viruses to which
many mouse cells are susceptible.

They also have a number of properties

which surprise us less (unusual chromatin distribution, characteristic
enzyme activities, particular adhesive properties, etc.),

but which

may nonetheless have important developmental implications.

Some of

these properties may be contingent on others; for example, and for
reasons that are not yet obvious, susceptibility to SV40 infection may
be incompatible with totipotency, or with F9 antigen expression.
Somatic cell hybridization provides an opportunity to dissect such
an association of properties epigenetically. The studies of Minna
et al. (1972) and of Szpirer and Szpirer (1975) have provided surprising
glimpses of control mechanisms in neuroblastoma and hepatoma cells,
respectively.

If an ECC-Friend cell hybrid, for example, were shown to

be pluripotent, but yet MVM-susceptible, one could conclude that what
ever metabolic specializations endowed cells with resistance to MVM
were incidental, rather than fundamental, to the totipotent state.
All the PCT and PCF hybrid clones resemble embryonal carcinoma
cells in each of the properties tested— enzymatic, viral, developmental,
and antigenic— -with the likely exception of the H-2 antigens discussed
just above.

Tl^ few structural differences found (e.g. nucleolar

number in the hybrids is usually greater than in the PCC4azal parents,
and cell size is also somewhat larger) may be due simply to the greater
ploidy of the hybrids; nucleolar number of tetraploid, pluripotent ECCs
has not, to my knowledge, been reported.

The marginally higher content

of globin mRNA sequences in PCF cells, as compared to other Friend cell
hybrids and to PCC4azal controls, may be a more significant exception,
and is still under investigation (Skoultchi, Miller, and Ruddle, in
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preparation).

Continued association of all these ECC properties In

two kinds of hybrids clearly does not prove that any of the traits
depends on any of the others, such less reveal the nature of the link.
Dissociation may be brought about in other hybrid combinations, or in
some other kind of experiment altogether.

The most one can say is

that the intertypic hybridizations reported here provide no evidence
that any of the ECC-specific properties can be expressed (or extin
guished) independently of the vhole set.
This discussion has encompassed a fair number of still-unansvered
questions.
exploration.

I wish to close by mentioning one other avenue for future
It will soon be routine to transfer portions of the

human genome, ranging in size from the entire diploid set, to individual
chromosomes, to small sections of chromosomes, and at high efficiency,
into any mouse cell which lacks HGPRT.

The results presented in this

dissertation make it seem likely that at least some of the resultant
partial hybrids will be pluripotent.

It is likely, too, that these

cells will produce the enzymes, antigens (including human "T/t" anti
gens), etc., characteristic of the early and inaccessible stages of
human embryogenesis, and hence not easy to obtain in other ways.
Furthermore, it is not at all impossible that these partial hybrids, if
injected into the blastocyst cavity of early mouse embryos, will par
ticipate in the formation of a mosaic mouse.

It would be interesting,

I think, to see how the human genes which mediate such embryonic
decisions as growth rate, size, germ layer orientation, etc., in which
mouse and human embryos differ, would interact with the intact mouse
genome in these "embryogenic" hybrid cells.
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